Synthesis of 1,2-diamines using nitrogen-containing heterocyclic templates by Iacobini, Greg
  
 
University of Warwick institutional repository: http://go.warwick.ac.uk/wrap  
 
A Thesis Submitted for the Degree of PhD at the University of Warwick 
 
http://go.warwick.ac.uk/wrap/53754 
 
 
This thesis is made available online and is protected by original copyright.  
Please scroll down to view the document itself.  
Please refer to the repository record for this item for information to help you to 
cite it. Our policy information is available from the repository home page.  
 
 
 
 
	    
	   1	  
 
 
 
 
 
Synthesis of 1,2-Diamines using Nitrogen-
Containing Heterocyclic Templates 
 
by 
Greg Iacobini 
 
A thesis submitted in partial fulfillment of the requirements 
For the degree of Doctor of Philosophy in Chemistry 
 
Department of Chemistry, University of Warwick 
July 2012
	    
	   2	  
Table of Contents 
Acknowledgements           4 
Declaration            5 
Abstract            6 
Abbreviations            7 
Chapter 1: Introduction to 1,2-Diamines      10 
1.1 Introduction         11 
1.2 1,2-Diamines in Natural Products      11 
1.3 1,2-Diamines in Medicinal Chemistry      13 
1.4 Applications in Synthetic Chemistry      16 
1.4.1 1,2-Diamines as chiral auxiliaries and resolving agents   17 
1.4.2 1,2-Diamines as chiral ligands       18 
1.4.3 1,2-Diamines as organocatalysts      24 
1.5 Current Routes to 1,2-Diamines       26 
1.5.1 Diamination of alkenes        27 
1.5.2 1,2-Diamines from β-amino alcohols and 1,2-diols    30 
1.5.3 1,2-Diamines from bis-imines       33 
1.5.4 Miscellaneous 1,2-diamine syntheses      34 
1.5.5 Summary         37 
Chapter 2: Nitrogen-Containing Heterocycles with an Endocyclic Double Bond 38 
2.1 Introduction         39 
2.2 1,2-Diazetines         40 
2.2.1 Introduction         40 
2.2.2 Background         41 
	    
	   3	  
2.2.3 Synthesis of 1,2-diazetines       48 
2.2.4 Conclusions         53 
2.3 Imidazolin-2-ones         54 
2.3.1 Introduction         54 
2.3.2 Background         55 
2.3.3 Synthesis and reactions of imidazolin-2-ones     58 
2.4 Conclusions         69 
Chapter 3: Nitrogen-Containing Heterocycles with an Exocyclic Double Bond 70 
3.1 Introduction         71 
3.2 Methyleneimidazolidinones       72 
3.2.1 Introduction         72 
3.2.2 Background         72 
3.2.3 Reactions of N-tosyl-methyleneimidazolidinone    75 
3.2.4 Conclusions         84 
3.3 3-Methylene-1,2-diazetidines       86 
3.3.1 Introduction         86 
3.3.2 Functionalisation of 3-methylene-1,2-diazetidines    90 
3.3.3 Hydrogenation studies of 3-methylene-1,2-diazetidines   96 
3.3.4 N−N bond cleavage and assignment of stereochemistry            107 
3.3.5 Other reactions of 3-methylene-1,2-diazetidines             110 
3.4 Conclusions and Future Work                118 
Chapter 4: Experimental                 121 
References                   163 
Appendix                                                                                       172 
 
	    
	   4	  
Acknowledgements  
 
First and foremost I wish to thank my Supervisor Professor Mike Shipman. Not 
only allowing me to undertake such an interesting and challenging project, but 
also for all the help, time and guidance he has provided me with these last few 
years, it is very much appreciated. In addition I would like to thank my CASE 
supervisor Dr. David Porter for taking the time to be involved in this project and 
for all the help and input he has offered, particularly during my three-month 
placement at the Novartis site in Horsham. 
 
I’d like to thank the University of Warwick, the EPSRC and Novartis for 
providing me with the funding and facilities that made this possible. In addition, 
all the technical staff, particularly Dr. Lijiang Song, Dr. Adam Clarke, and Dr. 
Ivan Prokes, as well as Dr. Guy Clarkson for help with X-ray crystallography. 
 
A big thank you to all of my friends, in particular the past and present members 
of the Shipman group: Mark, Claire, Matt, Pete, Emma, Karen, Mike, Penny, 
Alex, Sammi, Thuy, Amelie, Fran, Nicola, Ben and Sam who have been 
fantastic for not only providing a great deal of advice and aid in the lab, but also 
for making the past few years fun and enjoyable. 
 
Last and by no means least, I want to thank my parents, Pam and Paul, as I 
never would have made it this far without their encouragement and support.  
 
      
	    
	   5	  
Declaration 
 
Except where indicated, the work reported in this thesis is an account of my 
own independent research at the University of Warwick and at Novartis, 
Horsham, carried out between October 2007 and October 2010. I certify that no 
material within this thesis has been submitted for a prior degree or a degree at 
another university. 
 
Signed: 
Date:                                      
 
 
 
 
 
 
 
 
 
 
 
 
 
	    
	   6	  
Abstract 
 
This thesis describes the development of new methods for the synthesis of 1,2-
diamines. Chapter one reviews current methods for the synthesis of 1,2-
diamines, and their importance in chemistry. Chapter two highlights attempts to 
synthesise 1,2-diamines using two nitrogen-containing heterocycles, namely 3-
phenyl-1,3,5-triazabicyclo[3.2.0]hept-6-ene-2,4-dione and imidazolin-2-one, 
which both contain an endocyclic double bond. It includes the synthesis of a 
novel 1,2-diazetine as well as the functionalisation of imidazolin-2-one via a 
palladium-catalysed cross-coupling reaction with phenyl iodide. Subsequent 
hydrogenation and hydrolysis was then utilised to afford 1-phenylethane-1,2-
diamine dihydrochloride. Chapter three describes the synthesis and 
functionalisation of a range of 3-methylene-1,2-diazetidines that were 
subsequently hydrogenated in an asymmetric fashion, with [Rh(NBD)2]BF4 and 
ligand Mandyphos M004-1, to yield 1,2-diazetidines with up to 89% ee. 
Reduction with LiDBB allowed for the synthesis of two carbamate-protected 
1,2-diamines in three steps. The first examples of epoxidation, reaction with 
tetracyanoethylene and 1,3-dipolar cycloadditions of 3-methylene-1,2-
diazetidines are reported. Chapter four details the experimental procedures and 
characterisation data for the novel compounds produced. 
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1.1 Introduction 
This thesis describes the development of new synthetic routes to 1,2-diamines. 
The 1,2-diamine moiety 1 consists of 2 vicinal amino groups on a carbon 
backbone (Figure 1.1). It is therefore appropriate to discuss the importance of 
this class of compounds in various areas of science, as well as discussing 
current methods for their synthesis. A number of excellent reviews describing 
this topic have been published.1-5 We highlight work of most relevance to our 
studies in this chapter. 
                                                      
Figure 1.1 
 
1.2 1,2-Diamines in Natural Products 
1,2-Diamines are found in a wide range of natural products, many of which 
have important biological functions.2 For example, Biotin (vitamin H) 2 is an 
essential cofactor to carboxylase-catalysed reactions; it contains the 1,2-diamino 
moiety within an imidazolidinone ring (Figure 1.2).6  
                                             
Figure 1.2 
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Penicillin 3, the well-known family of antibiotics, contains a 2,3-diamino 
carboxylic acid unit within the penam skeleton (Figure 1.3). 
                                          
Figure 1.3 
 
A similar motif is found in other β-lactam antibiotics such as Cephalosporin A 4 
and the monobactam Aztreonam 5  (Figure 1.4). 
                             
                                    
Figure 1.4 
 
Many natural products, in particular non-ribosomal peptides, possess a diamino 
carboxylate substructure.7 These can be found within several families of 
antibiotics including edeines and tuberactomycin derivatives.8 Vicinal diamines 
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are also found within a number of alkaloids, known for their toxic properties, 
such as mimosine 6 and slaframine 7 (Figure 1.5).9,10 
                           
Figure 1.5 
 
1.3 1,2-Diamines in Medicinal Chemistry 
In addition to natural products, many synthetic compounds containing the 1,2-
diamine functionality have been used for medicinal purposes including 
antiarrhythmics and anticancer drugs.11-13 This section will highlight some 
important examples. 
 
Cisplatin 8 was found to have anticancer properties by Rosenberg in the 
1960s.14 Since this discovery there has been a great deal of interest in 
developing diamine-platinum complexes that possess greater activity and fewer 
side effects than Cisplatin, as well as overcome drug resistance that can develop 
in certain tumours. There are currently several diamine-platinum medicines on 
the market, including heptaplatin 9 and oxaliplatin 10 (Figure 1.6).15,16 
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Figure 1.6 
 
Ethylenediaminetetraacetic acid (EDTA) 11 is a synthetic 1,2-diamine that has 
found use both within industry and medicine due to its ability to bind to metal 
ions. It is commonly used in chelation therapy for the removal of excess iron in 
the body as well as for conditions such as mercury and lead poisoning (Figure 
1.7). 17 
                                             
Figure 1.7 
 
The quinolones are a family of synthetic broad-spectrum antibiotics, a number 
of which contain vicinal diamines within heterocyclic substituents.18 Examples 
include Lomefloxacin 12, used for the treatment of bronchitis and urinary tract 
infections, and Moxifloxacin 13, which can be used to treat a number of 
infections such as bacterial pneumonia and meningitis (Figure 1.8).19,20 
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Figure 1.8 
 
Cyclic 1,2-diamines form key parts of the antiviral drugs Oseltamivir 
(TamifluTM) 14 and Zanamivir (RelenzaTM) 15. Both have been used extensively 
against influenza A and B viruses (Figure 1.9). 21,22 
                                       
Figure 1.9    
       
In 2009 Yao et al. identified a number of 1,2-diamines, such as 16, that possess 
potent antituberculosis activity (Figure 1.10).23 Tuberculosis remains one of the 
worlds most deadly infectious diseases and with the development of antibiotic-
resistant strains, new medicines for its treatment are highly sought-after. 24   
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Figure 1.10 
 
More recently Daelemans et al. have reported the inhibition of HIV-1 
replication by bis-thiadiazolbenzene-1,2-diamine 17 (Figure 1.11).  These 
results may aid the development of next generation treatments for HIV.25  
                                            
Figure 1.11 
 
1.4 Applications in Synthetic Chemistry 
1,2-Diamines are an important class of compounds within organic synthesis, not 
only as intermediates towards other compounds but also as ligands, chiral 
auxiliaries and catalysts.2 1,4-Diazabicyclo[2.2.2]octane (DABCO, 18) has been 
used extensively as a base, as well as a catalyst for the Baylis-Hillman reaction 
and polyurethane production.26,27 In addition, compounds such as 
tetramethylethylenediamine (TMEDA, 19) are frequently used as additives in 
reactions to stabilise inorganic salts and organometallic reagents (Figure 1.12).28 
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Figure 1.12 
 
This section will highlight some of the various different applications that 1,2-
diamines have been used for within synthetic chemistry. 
 
1.4.1 1,2-Diamines as chiral auxiliaries and resolving agents 
Chiral auxiliaries are used for incorporating temporary chirality into an 
otherwise achiral molecule, thus allowing asymmetric reactions to be carried 
out.29 Since the introduction of chiral auxiliaries there has been much 
development in the area and in a number of cases, the 1,2-diamine moiety is 
present within the auxiliary.1 For example, Hanessian et al. have demonstrated 
the use of chiral phosphonamide 21, derived from 1,2-diamine 20, as a chiral 
auxiliary for the synthesis of 22 in excellent yield and enantioselectivity 
(Scheme 1.1).30 
 
Scheme 1.1 
 
 Mangeney et al. have shown that symmetrical 1,2-diamines such as 23 can act 
as simple but effective resolving agents for chiral aldehydes 24.31-33 Aminal 
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intermediates 25 offer a number of advantages over acetal analogues; no 
catalyst is required for their formation and they show excellent selectivity for 
aldehydes over ketones (Scheme 1.2).  
  
Scheme 1.2 
 
An alternative approach to resolve racemic compounds has been developed via 
the protonation of prochiral lithium enolates. For example, Vedejs and Lee have 
reported the use of chiral 1,2-diamines 26 for the enantioselective protonation of 
the amide enolate derived from amide 27 (Scheme 1.3).34 
          
Scheme 1.3 
 
1.4.2 1,2-Diamines as chiral ligands 
There has been an extensive amount of research into the use of chiral 1,2-
diamine ligands for the stereoselective addition of organometallic reagents to 
aldehydes and ketones.35-38 Knochel et al. have demonstrated this with the 
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addition of dialkylzinc reagents to aldehydes 28 in the presence of Ti(OiPr)4   
and disulfonamide 29 to give excellent enantioselectivities of the resulting 
secondary alcohols 30 (Scheme 1.4).39 
                 
Scheme 1.4 
 
In 1986, Koga and Simpkins first described independently the use of chiral 
lithium amide bases to stereoselectively deprotonate ketones.40,41 Many of the 
best chiral bases are derived from 1,2-diamines, including several of those first 
reported by Koga. For example, achiral cyclohexanone 31 can be preferentially 
deprotonated with 32 to form enolate 33, from one side over the other due to the 
asymmetry imparted by the base. In this way, silyl enol ether 34 can be formed 
in moderate to good enantioselectivity  (Scheme 1.5).42 
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The stereoselective addition of organolithium compounds to imines 35 in the 
presence of chiral 1,2-diamine 36 to yield enantiomerically enriched amines 37 
has been reported by Cabello et al. (Scheme 1.6).43 
         
Scheme 1.6 
 
Corey and co-workers described the use of aluminium Lewis acid catalyst 38, 
based upon a chiral 1,2-diamine scaffold, for stereoselective Diels-Alder 
reactions.44-45 Cycloadduct 41, formed from diene 39 and oxazolidinone 40, is 
an important intermediate for prostaglandin synthesis (Scheme 1.7).46 
       
Scheme 1.7 
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More recently, Evans et al. have demonstrated the use of a [CuII(salen)] 
complex as stereoselective catalyst 42 for Diels-Alder reactions. The 
cycloaddition of 43 and cyclopentadiene in the presence of 42 affords 44 in 
excellent yields and varying enantioselectivity  (Scheme 1.8).47 
        
Scheme 1.8 
 
Jacobsen et al. have reported the use of similar types of salen ligands, such as 
45, for the enantioselective copper-catalysed aziridination of unfunctionalised 
alkenes 46 to yield a variety of enatiomerically enriched aziridines 47-49 
(Scheme 1.9).48 
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Scheme 1.9 
 
Asymmetric hydrogenation is arguably one of the most important and widely 
used enantioselective reactions.49,50 In particular, asymmetric transfer 
hydrogenation reactions have received much attention in recent years.51 Transfer 
hydrogenations rely on a source of hydrogen such as formic acid or IPA, which 
in the presence of a transition metal catalyst can hydrogenate unsaturated 
functional groups such as imines and ketones. Noyori has demonstrated how 
ruthenium catalysts with chiral 1,2-diamine ligands, such as 50, can reduce a 
wide range of ketones 51 to the corresponding alcohols 52 with excellent 
enantioselectivities (Scheme 1.10).52 
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Scheme 1.10 
 
In 2010 Du et al. were successful in coupling cyclic enones 53 with aryl boronic 
acids to furnish 54 in moderate to excellent enantioselectivity using a rhodium-
based catalyst and chiral diamine 55 as a ligand (Scheme 1.11).53 
                           
Scheme 1.11 
 
More recently, Wan et al. have utilised 1,2-diamine 56 as a ligand for a copper-
catalysed asymmetric Friedel-Crafts alkylation of indoles 57 with nitroalkenes 
58 to give substituted indoles 59 with excellent yields and enantioselectivities 
(Scheme 1.12).54  
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Scheme 1.12 
 
1.4.3 1,2-Diamines as organocatalysts 
In recent years there have been many reports of reactions that utilise 1,2-
diamines as catalysts themselves.55  For example,  Pansare and Pandya have 
demonstrated that proline-derived 1,2-diamine 60 is capable of catalysing the 
asymmetric Michael addition of cyclic ketones 61 to nitroalkenes 62 to yield 63 
with excellent enantioselectivities (Scheme 1.13).56 
               
Scheme 1.13 
 
The asymmetric catalysis of cycloadditions with 1,2-diamines have also been 
developed. For example Chen and co-workers have reported organocatalyst 64, 
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derived from 1,2-diamino cyclohexane, that catalyses the 1,3-dipolar 
cycloaddition of nitrones 65 and nitroalkenes 66 to form isoxazolidines 67, with 
good enantioseletivity and excellent diastereoselectivity (Scheme 1.14).57 
 
Scheme 1.14 
 
In 2010, Lei and co-workers described the use of N,N’-
dimethylethylenediamine (DMEDA 68) as a catalyst to promote C-H arylation 
of unactivated benzene with aryl iodides 69.58 The mechanism is believed to 
involve an aryl radical anion intermediate and offers considerable scope for 
coupling reactions of substrates that are sensitive to transition metal-based 
catalysts (Scheme 1.15). 
                  
Scheme 1.15 
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1.5 Current Routes to 1,2-Diamines 
Since 1,2-diamines have important applications in many areas of chemistry, 
there is considerable interest in developing new, efficient methods for their 
synthesis. In particular, pathways that will yield enantiomerically pure 1,2-
diamines are much sought after.2-3 Currently, there are a variety of different 
methods available for the synthesis of 1,2-diamines described in the literature; 
however, each approach usually has some limitations. A number of different 
synthetic routes have been employed such as the diamination of alkenes, the ring 
opening of aziridines and imine coupling (Scheme 1.16). This section will 
outline some of the most important methods that have been applied in the 
synthesis of 1,2 diamines in recent years.  
 
               
Scheme 1.16 
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1.5.1 Diamination of alkenes 
The direct addition of two nitrogen atoms across an olefin can be considered to 
be one of the most attractive routes for the synthesis of 1,2-diamines.  However, 
unlike the analogous dihydroxylation reaction, which has enjoyed much success, 
the diamination of alkenes has received relatively little attention.59    
 
In 1974, Barluenga and co-workers reported the diamination of olefins 71 to 1,2-
diamines 72 using thallium (III) acetate. This process is limited to aryl amines 
and possesses no enantioselectivity or diastereoselectivity. In addition, thallium 
salts are known to be highly toxic and their use in large quantities is undesirable 
(Scheme 1.17).60 
            
Scheme 1.17 
 
 A few years later Sharpless and co-workers developed a synthetic route to 1,2-
diamines 75 via reaction of triimidoosmium 73 with monosubstituted and 
disubstituted E-olefins 74.61 The reagent undergoes a stereospecific addition to 
the alkenes to give cis 1,2-diamines as the major products. This synthesis 
requires a stoichiometric equivalent of 73, which must be prepared from the 
costly and highly toxic OsO4. In addition, this synthesis is only compatible with 
E-alkenes and no absolute stereochemical control is possible (Scheme 1.18).  
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Scheme 1.18 
 
In 2001, Li and co-workers reported the catalysed diamination of enones 76. 
This was achieved in the presence of a rhodium catalyst and offers good 
diastereomeric control. The resulting heterocycles 77 have been shown to 
undergo hydrolysis (R = OMe) with hydrochloric acid to yield protected 1,2-
diamine 78 (Scheme 1.19).62  
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Since Li’s findings there has been increased interest in the area and several 
groups have reported the enantioselective diamination of olefins.63-66 For 
example, in 2007 Shi et al. demonstrated the asymmetric diamination of dienes 
79 with di-tert-butyldiaziridinone (80) using Pd2(dba)3 as a catalyst and BINOL-
based ligand 81.67 This reaction affords a range of disubstituted imidazolidinones 
82 which can be hydrolysed to 83 and finally to the corresponding 1,2-diamine 
84 with excellent enantioselectivities (Scheme 1.20). 
 
Scheme 1.20 
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More recently Muniz and co-workers have reported the use of chiral hypervalent 
iodine complex 85 for the diamination of styrene derivatives 86.68 This synthesis 
offers an efficient route to chiral mesyl 1,2-diamines 87 with perhaps the only 
drawbacks being stoichiometric quantities of 85 needed as well as the forcing 
conditions required for the removal of the mesyl protecting groups to afford 88 
(Scheme 1.21). 
      
Scheme 1.21 
 
1.5.2 1,2-Diamines from β-amino alcohols and 1,2-diols  
The enantioselective syntheses of 1,2-diols and β-amino alcohols have received 
much attention and there are now a variety of effective methods available for 
their preparation.69-75 In addition, there are a number of optically active β-amino 
acids available from the chiral pool.76 As such, their use as intermediates for the 
synthesis of chiral 1,2-diamines offers an attractive, if sometimes lengthy, route.  
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Sharpless demonstrated the conversion of homochiral 1,2-diol 89 to the 
corresponding 1,2-diamine 92 by utilising azide substitution followed by 
catalytic hydrogenation. This method proceeds in overall modest yield, but with 
excellent enantioselectivity from an olefin, with the inclusion of a 
dihydroxylation reaction, this represents a four-step sequence. This synthesis is 
widely applicable, although clearly not very direct (Scheme 1.22).71 
                  
Scheme 1.22 
 
The reduction of amino acids offers a straightforward route to enantiomerically 
pure β-amino alcohols, which can be converted into 1,2-diamines, as 
demonstrated by Kokotos et al. with the synthesis of 96.77 Again, this is a rather 
lengthy process, and its reliance on the chiral pool generally limits its 
applicability to one enantiomeric series, and only a few substitution patterns 
(Scheme 1.23). 
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Scheme 1.23 
 
In 2004, Maruoka et al. reported a highly enantioselective synthesis of 1,2-
diamines 99 from protected α-amino acid amides 97 using a phase-transfer-
catalysed alkylation.78 This method utilises chiral ammonium salt 100 as the 
catalyst and leads to 99 in 2 steps (Scheme 1.24). 
 
Scheme 1.24   
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1.5.3 1,2-Diamines from bis-imines 
The electrophilicity and prochirality of bis-imines make them attractive 
templates onto which functional groups can be added for the synthesis of 1,2-
diamines. The example in Scheme 1.25 demonstrates the addition of two 
equivalents of a Grignard reagent to chiral bis-imine 102 template bearing two 
α-methyl-benzylamino groups to induce stereochemistry.79. Subsequent 
hydrogenation affords 1,2-diamine 104 in good yield and excellent 
diastereoselectivity. 
 
Scheme 1.25 
 
Kim and co-workers have adopted a different method using a diaza-Cope 
rearrangement. This approach allows an efficient synthesis of 1,2-diamines from 
two equivalents of aldehyde and enantiomerically enriched diamine 105, which 
acts as a sacrificial source of nitrogen. Formation of bis-imine 106 via diaza-
Cope rearrangement, followed by hydrolysis furnishes 107 (Scheme 1.26).80 
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Scheme 1.26 
 
1.5.4 Miscellaneous 1,2-diamine syntheses 
There is a wide range of other approaches for the synthesis of 1,2-diamines. This 
final section highlights some of the best of these. 
 
There are numerous well-established methods for the enantioselective synthesis 
of aziridines.81-84 As such, it comes as no surprise that the ring opening of 
aziridines with nitrogen-based nucleophiles has been employed for the synthesis 
of 1,2-diamines. The example in Scheme 1.27 demonstrates the ring opening of 
tri-substituted aziridine 108 with primary and secondary amines to afford 109 
under mild conditions and without the use of a Lewis acid catalyst (Scheme 
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1.27).84  Interestingly, SN2 attack occurs at the more substituted end of the 
aziridine; this is reported to be due to electronic activation from the alkyne. 
                  
Scheme 1.27 
 
In 2004, Xu and co-workers reported the asymmetric synthesis of 1,2-diamines 
112 via a reductive homocoupling of aromatic N-tert-butanesulfinyl imines 110 
in the presence of SmI2 and HMPA, followed by deprotection with HCl in 
methanol.85 This process offers a straightforward route to a range of 1,2-
diamines with excellent enantioselectivity but is unfortunately hindered by the 
requirement for two equivalents of SmI2 and HMPA (Scheme 1.28). 
 
Scheme 1.28 
 
Anderson et al. have recently utilised an asymmetric nitro-Mannich reaction for 
the synthesis of β-nitroamines 115 using copper catalyst 117 with 
trimethylsilylnitropropanate (113) and a variety of imines 114.86 These products 
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can then undergo reduction with SmI2 to yield a variety of enantiomerically 
enriched 1,2-diamines 116 (Scheme 1.29).87 
 
Scheme 1.29. 
 
Maruoka co-workers have also explored the use of asymmetric Mannich 
reactions for the enantioselective synthesis of 1,2-diamines. It has been shown 
that α-aminoaldehyde 118 reacts with imines 119 in the presence of an 
appropriate asymmetric catalyst to yield 1,2-diamines 120 or 121 with excellent 
enantioselectivities.88 Furthermore, the diastereoselectivity of the reaction can be 
controlled by altering reaction conditions and the choice of catalyst, with L-
proline (122) showing syn selectivity and sulfonamide 123 showing anti-
selectivity (Scheme 1.30). 
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Scheme 1.30 
 
1.5.5 Summary 
A wide variety of methods for the synthesis of 1,2-diamines have emerged. 
However relatively few of these examples achieve high levels of enantiomeric 
control and those that do are often limited in their versatility, allowing for only 
a narrow range of functionality to be introduced. In some cases the substituents 
are often incorporated into the product early in the synthesis, which can lead to 
a lengthy process when libraries of 1,2-diamines are required. Considering their 
abundance in biologically active compounds and their extensive utility in 
asymmetric synthesis, we believe there is still much scope for the development 
of further efficent synthetic routes to a wide range of enantiomerically enriched 
1,2-diamines. In the following chapters, we describe new approaches based 
upon the utilisation of heterocyclic templates for the enantioselective synthesis 
of 1,2-diamines. 
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Chapter 2: 
Nitrogen-Containing Heterocycles with an  
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2.1 Introduction 
In this thesis, we explore an alternative approach to the synthesis of 1,2-
diamines based upon the use of a variety of heterocyclic templates containing 
two vicinal nitrogen atoms. In this chapter, we describe efforts to use 1,2-
diazetine 124 and imidazolin-2-one 125 systems for this purpose (Figure 2.1). 
                                    
Figure 2.1 
 
124 and 125 were selected as candidates for this investigation as we believed 
their respective endocyclic double bonds could provide us with an appropriate 
method for functionalisation. We envisaged achieving this with a metal-
catalysed cross-coupling reaction followed by asymmetric hydrogenation. 
Subsequent cleavage of the heterocycle was then expected to be realised using 
literature methods, yielding the desired 1,2-diamine 129 (Scheme 2.1) 
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We also wished to investigate an alternative approach utilising cycloadditions, 
such as the Diels-Alder reaction, for the synthesis of cyclic 1,2-diamines 131 
(Scheme 2.2). 
 
 
Scheme 2.2 
 
Each heterocycle, 124 and 125, will be discussed separately, beginning with 
background information from the literature regarding their synthesis and known 
reactions, including potential cleavage techniques. Our efforts to use them as 
templates for the synthesis of 1,2-diamines will then be presented.   
 
2.2 1,2-Diazetines 
2.2.1 Introduction 
There are very few reports of 1,2-diazetines in the literature, as their synthesis 
poses a significant challenge.89 By comparison, 1,2-diazetidines (the saturated 
analogues of 1,2-diazetines) have received more attention and there are a 
number of known routes for their synthesis.90-92 Furthermore, many of the 
known examples of 1,2-diazetines are as part of larger, more complex 
molecules and as such are not suitable for our purposes. We will therefore only 
be concerned with such examples that are relevant to this study. 
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This section will review the known methods for the synthesis of 1,2-diazetines 
and their reported reactions. In addition, methods for the cleavage of N−N 
bonds, which will be required for the synthesis of the desired 1,2-diamines, will 
be discussed. 
 
2.2.2 Background 
To our knowledge, Warrener and Nunn reported the first known synthesis of a 
1,2-diazetine in 1972.93 Synthesis of 138 was achieved beginning with a 
cycloaddition between dimethylazodicarboxylate (133) and in situ generated 
cyclobutadiene via oxidation of the corresponding Fe(CO)3 complex 132, to 
yield diazabicyclohexane 134, which undergoes a second cycloaddition with 
2,5-dimethyl-3,4-diphenylcyclo-penta-2,4-dienone (135) to furnish tricycle 136. 
Irradiation of 136 with ultraviolet light led to rearrangement with loss of carbon 
monoxide followed by 1,2-photoaromatisation, via [2+2] electrocyclic ring-
opening of the central ring, to give 1,4-dimethyl-2,3-diphenylbenzene (137) and 
1,2-diazetine 138. In this instance, 138 was converted to the corresponding 1,2-
diazetidine 139 by catalytic hydrogenation using palladium on carbon (Scheme 
2.3). 
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Scheme 2.3 
 
Diazetine 138 is thermally unstable and is reported to undergo electrocyclic 
ring-opening to give 140 with a half life of 6.9 h at 25 oC (Scheme 2.4). 
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Fe(CO)3
N
N
CO2Me
CO2Me
N
N
CO2Me
CO2Me
Me
Me
Ph
Ph
CON
N
CO2Me
CO2Me
Me
Me
Ph
Ph
NN
CO2MeMeO2C
NN
CO2MeMeO2C
(NH4)2Ce(NO3)6
31%
N N
CO2Me
MeO2C
+
O
MeMe
PhPh
hv, CDCl3
0 oC
H2, Pd/C
Me
Me
Ph
Ph
+
132
133
134
135
136
137
138 139
NN
MeO2C CO2Me NCO2MeMeO2CN25 oC
138 140
	    
	   43	  
More recently, Breton et al. have reported the thermally stable, bicyclic 
diazetine 144.89 Its synthesis is achieved by oxidation of N-methyl urazole with 
trichloromelamine to give N-methyltriazolinedione (141), which was then 
reacted with phenyl vinyl sulfide. Oxidation of the resulting 142 with m-CPBA 
and subsequent elimination afforded 144 (Scheme 2.5).  
 
Scheme 2.5 
 
 
Bicyclic diazetine 144 is reported to be a thermally stable crystalline solid that 
can be sublimed.  Breton argues that electrocyclic ring opening of 144 would be 
unfavourable as product 145 would be a highly strained seven-membered ring. 
Furthermore, ring opening would likely be reversible as the back reaction is still 
intramolecular (Scheme 2.6).  
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Scheme 2.6 
 
 
Breton has also demonstrated that 144 can act as a suitable dienophile for Diels-
Alder reactions with a variety of dienes. Yields range from modest to excellent, 
with high selectivity for endo products. In addition, it was shown that the 
products could be converted to Δ1-1,2-diazetines 148 via deprotection and 
oxidation. No attempts to reduce diazetidine 147 to the corresponding cyclic 
1,2-diamines by cleavage of the N−N bond were reported (Scheme 2.7). 
                          
Scheme 2.7 
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(Scheme 2.5). The low yielding step involves cycloaddition of phenyl vinyl 
sulfide with triazolinedione 141, as copolymer formation is competitive. Breton 
reported that attempts to improve the yield of 144 with variation in reaction 
conditions or solvent were unsuccessful. These findings are consistent with 
those of several other groups who have investigated the cycloaddition of olefins 
with azo-compounds.94-96 For example, Hall  and Jones have reported that the 
cycloaddition of ethyl and phenyl vinyl ethers, 150 and 151, with N-phenyl 
triazolinedione (149) results in the formation of copolymer 152 (Scheme 2.8).97 
             
 
Scheme 2.8 
 
In contrast, the reaction of 2-chloroethyl vinyl ether (153) with 149 is reported 
to furnish diazetidine 154 in quantitative yield  (Scheme 2.9). 
      
Scheme 2.9 
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a number of other groups have made similar observations on related systems 
and have also suggested copolymer formation. The analytical data provided for 
1,2-diazetidine 154 consists of a melting point, CHN analysis and 1H NMR 
spectrum displaying an ABX pattern that Hall rationalises as evidence for a 
diazetidine structure. In addition, reaction of 153 with 149 in acetone is reported 
to give tetrahydrooxadiazine 156. This suggests that the reaction is not 
concerted and involves zwitterionic intermediate 155, which can be trapped 
with an appropriate reagent such as acetone (Scheme 2.10). 
    
Scheme 2.10 
 
Clearly the reaction is sensitive to the electronic nature of the olefin. One might 
expect an electron-withdrawing group present in the vinyl ether (e.g. 
ClCH2CH2O-) may destabilise the zwitterionic intermediate 155, promoting a 
fast intramolecular ring closing reaction as opposed to intermolecular 
polymerisation. Manipulation of the substituent on the olefin may therefore 
allow for improvements in the yield of compounds such as 1,2-diazetine 144.  
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diamine 158 using diborane for both carbonyl reduction and N−N bond 
cleavage (Scheme 2.11).99 
                            
Scheme 2.11 
 
More recently, Shipman and co-workers have demonstrated N−N bond cleavage 
of 1,2-diazetidine 159 with LiDBB in good yield (Scheme 2.12).100 
                        
Scheme 2.12 
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compounds could be used as useful templates for 1,2-diamine synthesis. 
However, it seemed unlikely that thermally unstable diazetines such as 138 
reported by Warrener and Nunn would be suitable for our purposes. Even if 138 
could be synthesised and used directly, reactions for further functionalisation 
(e.g. cycloadditions) are likely to require heating. Bicyclic diazetine 144 is a 
more attractive substrate, providing its synthesis can be improved. Based on the 
investigations of Hall and Jones this is expected to be possible by variation of 
the vinyl sulfide substrate, as the reaction appears to be quite sensitive to the 
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other cycloadditions, such as a 1,3-dipolar cycloaddition, or Heck reactions 
followed by asymmetric hydrogenation would be of interest. Subsequent 
deprotection and cleavage of the N−N bond using known literature procedures 
should then allow us to obtain a variety of 1,2-diamines, such as 161 and 164, 
through a potentially divergent process (Scheme 2.13).  
 
Scheme 2.13 
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following column chromatography of 166 suggested polymer formation, 
however this was not characterised further. The overall yield for this sequence 
was very low, although not dissimilar to that reported by Breton for the N-
methyl series (Scheme 2.5). 
                      
Scheme 2.14 
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Scheme 2.15 
 
This work indicated that the less expensive N-phenyl derivative 149 could be 
used in place of the N-methyl compound. However, with an overall yield of less 
than 10%, it was clear that this chemistry was far from practical. We therefore 
considered what alternatives to phenyl vinyl sulfide would be expected to 
favour formation of diazetidine 165 over polymer. Based on Hall’s observations 
(Schemes 2.8 and 2.9), some form of electron-withdrawing group on the vinyl 
sulfide might assist formation of the four-membered ring.97  
 
By analogy with the earlier study, the obvious choice would be 2-chloroethyl 
vinyl sulfide 169, however this is expected to be extremely toxic, and 
potentially carcinogenic, based on its structural similarities to bis(2-chloroethyl) 
sulfide (mustard gas, 168).101 Indeed, to our knowledge all the known 
procedures for the synthesis of 169 require bis(2-chloroethyl) sulfide as a 
precursor (Scheme 2.16).102 
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As such, it was concluded that this would not be a suitable substrate to 
investigate. Compounds with electron-withdrawing groups present on the 
phenyl ring of phenyl vinyl sulfide, such as 170-172, were considered as 
alternatives (Figure 2.2). 
                  
Figure 2.2 
 
Due to the availability of 2,4-dinitrobenzenesulfenyl chloride, 172 was selected 
for investigation. It was synthesised via the known reaction of 2,4-
dinitrobenzenesulfenyl chloride with vinyl trimethylsilane, followed by 
elimination by heating in ethanol (Scheme 2.17).103 The distinctive olefinic 
pattern in the 1H NMR spectrum of 172 was consistent with the literature, 
indicating the synthesis was successful. Reaction with 149 was then attempted. 
Unfortunately, this led to a complex mixture of products from which nothing 
could be isolated that resembled the desired 1,2-diazetidine 174 after further 
oxidation with m-CPBA (Scheme 2.17). 
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Scheme 2.17 
 
It is possible that a less electron-withdrawing alternative such as 170 or 171 
would prove to be a more suitable substrate, however more steps are required 
for the synthesis of such compounds, leading to an increasingly lengthy 
synthesis that would not be considered practical. As an alternative, the 
cycloaddition was attempted with phenyl vinyl sulfoxide, as this would yield 
166 directly if successful. Unfortunately no reaction was observed at room 
temperature, or when heated to 100 oC in a sealed tube (Scheme 2.18). 
                
Scheme 2.18 
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Olefins 175-177 with heteroatoms of a different electronic nature to sulfur were 
then considered. It was believed that if such compounds could be successfully 
reacted with 149 to furnish the corresponding diazetidines in good yield, then 
alternative methods for their further functionalisation could be investigated. 
Therefore reaction of 149 with these commercial olefins was attempted. 
However, in each case, complex mixtures were obtained with no sign of 
bicycles 178-180 being observed (Scheme 2.19). 
            
Scheme 2.19 
        
2.2.4 Conclusions 
 
It has been shown that N-phenyl urazole can be used in place of N-methyl 
urazole in Breton’s route to bicyclic 1,2-diazetines. However, the approach 
suffers from similar problems to the literature method, namely very low yields 
for the “cycloaddition” step. Efforts to circumvent these problems by tuning the 
nature of the sulfide substituent, or by using alternative heteroatoms were 
uniformly unsuccessful. As such, progress to developing a practical route to 1,2-
diamines based upon the 1,2-diazetine scaffold was thwarted. 
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2.3 Imidazolin-2-ones 
 
2.3.1 Introduction 
 
In contrast to 1,2-diazetines, imidazolin-2-ones (and their saturated analogues 
imidazolidin-2-ones) have enjoyed much attention in the literature.104-108 Reports 
for the synthesis of such compounds, both functionalised and unfunctionalised 
go back over a century.109 We imagined that such systems might serve as 
alternatives to 1,2-diazetines in 1,2-diamine synthesis, as they are not only 
expected to be more stable than 1,2-diazetines but there are also more 
established methods for their synthesis. However, the less strained double bond 
of imidazolin-2-ones compared to 1,2-diazetines, as well as the potential 
aromatic character of the ring may result in lower reactivity. We wanted to 
investigate similar methods for their functionalisation as previously discussed 
for 1,2-diazetines, namely cycloadditions and Heck reactions, followed by 
cleavage to yield the desired 1,2-diamines (Scheme 2.20). 
 
Scheme 2.20 
NN
O
4R
R11RHeckNN
O
R11RNN
O
R11R
NN
O
4R
R11R
asymmetric
hydrogenation
4R
H2N NH2 cleavage
R32R
cleavage
cycloaddition
e.g. Diels-Alder
125
182
183129
R32R
NH2H2N
181
131
	    
	   55	  
 The following section will briefly highlight literature methods for their 
synthesis, suitable reactions for their functionalisation as well as methods for 
their hydrolysis to the corresponding diamines. 
 
 
 
2.3.2 Background 
 
The synthesis of unsubstituted imidazolin-2-one 185 is easily achieved via the 
reduction of hydantoin 184 and subsequent elimination of the resulting hydroxyl 
group, as described by Whitney (Scheme 2.21).108 
                                        
Scheme 2.21 
 
A similar approach reported by Liao and Kohn allows for the synthesis and 
functionalisation of imidazolinones 187 from N-benzyl hydantoin 186 in a 
single step (Scheme 2.22).110 
                            
Scheme 2.22 
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 Recently Chen and co-workers have described a palladium-catalysed cross-
coupling reaction of 185 with a variety aryl halides to give aryl-substituted 
derivatives 188 in moderate to good yields (Scheme 2.23).111 
                                   
Scheme 2.23 
 
Several groups have shown that diacetylated imidazolinone 189 will participate 
in Diels-Alder reactions. However, only a very limited number of dienes, such 
as very reactive cyclopentadiene have been used to date (Scheme 2.24).108, 112-114 
                      
Scheme 2.24 
 
Duschinsky and Kohn have both reported the hydrogenation of imidazolinone 
191 (Scheme 2.25).115,116 These reactions used palladium on carbon as the 
catalyst, and as far as we are aware, the influence of chiral catalysts on these  
transformations has not been explored. 
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Examples of stereoselective hydrogenations of imidazolinones are less 
common. To our knowledge, the most relevant example is a procedure patented 
by Lonza for the diastereoselective hydrogenation of bicyclic imidazolinone 
193 as part of a synthetic route towards biotin.117 In this case, the electronics of 
the double bond are likely influenced by the adjacent carbonyl group (Scheme 
2.26). 
 
Scheme 2.26 
 
There are many of examples in the literature for the hydrolysis of 
imidazolidinones to the corresponding 1,2-diamines.115, 118-121 This process is 
usually carried out under rather forcing conditions with either aqueous 
hydrochloric acid (Scheme 2.27), or a strong base such as barium hydroxide 
(Scheme 2.28).119,122 
                  
Scheme 2.27 
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Scheme 2.28 
 
Based on the literature precedent for the synthesis and reactions of 
imidazolinones, it was thought that such compounds would make appropriate 
templates for the synthesis of 1,2-diamines. We intended to utilise the routes 
described by Chen (Scheme 2.23) for the synthesis of a number of substituted 
imidazolinones. We would then explore asymmetric hydrogenations of these 
substrates and finally investigate their hydrolysis to the corresponding 1,2-
diamines, as described in Scheme 2.20.  
 
2.3.3  Synthesis and reactions of imidazolin-2-ones 
Imidizadolinone 185 was synthesised according to Whitney’s procedure 
(Scheme 2.21) and subsequently functionalised with phenyl iodide using Chen’s 
method (Scheme 2.23) to yield phenyl derivative 199 (Scheme 2.29). 
     
Scheme 2.29 
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Liao and Kohn’s route (Scheme 2.22) was utilised for the synthesis of 200, 
which had not been reported in their paper. This offered us an alternative 
substrate, with potentially enhanced solubility in organic solvents, for us to 
explore reductions (Scheme 2.30). 
         
Scheme 2.30 
 
Our attention then turned to the hydrogenation reactions of these substrates. We 
began with conventional heterogeneous catalysts, namely palladium on carbon, 
to gain some knowledge regarding the reactivity of the double bond. Reactions 
were carried out using an H-cube® continuous-flow hydrogenation reactor, as 
this allowed us to reach pressures that were otherwise unobtainable in the 
laboratory at the time.  To our surprise, hydrogenation of 199 to corresponding 
imidazolidinone 201 proved to be extremely difficult and was only achieved 
under very forcing conditions. Furthermore, the more hindered N-benzylated 
derivative 200 could not be hydrogenated to 202 at all (Table 2.1). 
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entry substrate R temp. (oC) pressure (bar) outcome 
1 199 H  25 1 No reaction 
2 200 Bn  25 1 No reaction 
3 199 H  25 20 No reaction 
4 199 H  50 50 No reaction 
5 199 H  100 100 201 (53%) 
6 200 Bn  100 100 No reaction 
 
Table 2.1 
 
 
Based on literature examples of similar substrates, which have been reported to 
be successfully hydrogenated at 3 bar at room temperature, these results were 
quite unexpected (Scheme 2.25).115,116 Possible causes for the lack of reactivity 
might be steric hindrance, solubility, as well as partial aromatic character of 
these substrates. Both 199 and 200 were insoluble in most solvents and only 
sparingly soluble in acetic acid, DMF and DMSO. Next, efforts focused on 
trying to improve the reactivity of these substrates. The hydrogenation of 
unsubstituted imidazolinone 185 was investigated, as this compound is both less 
hindered and more soluble in organic solvents than 199. Hydrogenation was 
achieved with slightly less forcing conditions, but still required high 
temperatures and pressures (Scheme 2.31).  
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Scheme 2.31 
 
These results indicated that there was more to the lack of reactivity than simple 
steric hindrance or solubility issues. The double bond of such imidazolinones 
may be rather aromatic in character, with involvement from the nitrogen lone 
pairs (Scheme 2.32). 
                                 
Scheme 2.32 
 
 By removing the lone pairs from the ring, by introduction of electron-
withdrawing substituents on N, the aromatic character of the heterocycle should 
be reduced. In this way, the reactivity towards hydrogenation might be 
significantly increased. To explore this idea, the hydrogenation of the 
diacetylated imidazolidinone 189 was attempted. We were pleased to observe 
that hydrogenation occurs readily at room temperature and pressure. 
Interestingly, the isolated product 205 had evidently had an acetyl group 
removed during the process (based on 1H NMR and mass spectroscopic data), 
presumably by attack from methanol. It is uncertain at which point in the 
reaction acetyl deprotection occurs. However, considering 189 was purified by 
recrystallisation from ethanol, it would be expected to be stable to methanol at 
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ambient temperature, suggesting deprotection occurs on 204 following the 
hydrogenation of 189 (Scheme 2.33).  
                        
Scheme 2.33 
 
In light of these results, we began to investigate the synthesis of other N-
substituted imidazolinones. It was hoped that diacetylated imidazolinone 189 
could be functionalised directly by Heck-type processes, as depicted in Scheme 
2.34, but unfortunately no reaction occurred under the conditions successfully 
used for the synthesis of 199 (Scheme 2.29).  
 
                 
Scheme 2.34 
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to be more difficult than expected, with only mono-acetylated 206 being 
obtained in moderate yield and only traces of 207 being observed. The best 
NHHN
O
NN
O
Ac
     68%
H2, Pd/CMeOH
25 oC, 18 h
1 bar
    Ac2O
150 oC, 1 h Ac
NN
O
AcAcNHN
O
Ac
185 189
204205
95%
NN
O       PhI, Pd(OAc)2NaOAc 3H2O, DMSO
80 oC, 6 h no reactionAcAc
189
	    
	   63	  
conditions found involved the use of acetyl chloride in DMF with triethylamine 
as base at 80 oC (Table 2.2). 
                       
entry X additives solvent time 
(h) 
temp. 
(oC) 
206 
(%) 
207 
(%) 
    1     OAc - - 4 150 5 trace 
2 OAc Et3N, DMAP DMSO 48 80 25 trace 
3 Cl Et3N, DMAP DMSO 16 80 - - 
4 Cl Et3N, DMAP DMF 3 80 42 trace 
5 Cl Et3N DMF 3 80 43 trace 
 
 Table 2.2 
 
Only one regioisomer of 206 was observed in the crude reaction mixture. The 
regioselectivity was initially unclear, with nOe studies being inconclusive. 
Gratifyingly, we were able to obtain suitable crystals for single crystal X-ray 
diffraction by crystallisation from ethyl acetate by slow evaporation. This X-ray 
structure confirmed that acylation occurred at the nitrogen atom furthest from 
the phenyl ring, presumably because it is the most sterically accessible (Figure 
2.3). 
                       
Figure 2.3 
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Two related substrates, namely 208 and 209, were then synthesised using 2-
methylpropanoyl chloride and 2,2-dimethylpropanoyl chloride respectively. 
These substrates were expected to have improved organic solubility compared 
with 206, and perhaps be less susceptible to attack by methanol under the 
hydrogenation conditions (Scheme 2.35).                           
  
Scheme 2.35 
 
Hydrogenation of 206 proceeds readily under mild conditions, using just a 
balloon of hydrogen to give the reduced product 210 in excellent yield. Hence it 
appears that removal of just one lone pair from the heterocycle is sufficient to 
markedly reduce its aromatic character (Scheme 2.36). 
 
                         
Scheme 2.36 
 
Phenyl substituted derivative 201 was readily hydrolysed to corresponding 
diamine 211 under acidic conditions in accordance with literature precedent.119  
The yield for this reaction was not optimised at this time (Scheme 2.37). 
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Scheme 2.37 
 
With a good understanding of the relative reactivities of these imidazolin-2-ones 
in hand, our attention now turned to the identification of chiral catalysts to 
effect asymmetric hydrogenations of these systems. Based on the reports by 
Lonza (Scheme 2.26), the use of rhodium catalysts with chiral Josiphos ligands 
appeared an appropriate place to begin.117 
 
Treatment of 206 with [Rh(NBD)2]BF4 and 1 atmosphere of hydrogen in the 
presence of (R)-1-[(SP)-2-(Diphenylphosphino)ferrocenyl]ethyldicyclohexyl- 
phosphine (Josiphos J001-1) for 16 h at room temperature resulted in no 
reaction (Table 2.3, entry 1). This bulky homogeneous catalyst was clearly 
insufficiently active to reduce the trisubstituted alkene under these very mild 
conditions.  Higher pressures did not increase the reactivity (entry 2). It was 
discovered that heating in methanol at 50 oC led to removal of the N-acetyl  
group (entry 3). Even the more hindered derivative 208 underwent cleavage 
under these conditions (entry 4). To circumvent this problem the solvent was 
switched to ethyl acetate. Again no reaction was observed under mild conditions 
(entries 6-8), and no improvements with made with THF as the solvent (entry 
9). Upon increasing the pressure and temperature however, complex mixtures 
were obtained (entries 10-11). We were unable to isolate any compounds from 
the crude mixture, but based on mass spectrometry evidence (m/z =207, [M+H]+ 
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+ 2) it appeared that the substrate had been over-reduced, possibly by cleavage 
of the ring and hydrogenation of the double bond to give 213  (Figure 2.4). 
                
entry substrate solvent pressure  
(bar) 
temp.  
(oC) 
outcome 
1 206 MeOH 1 25 no reaction 
2 206 MeOH 10 25 no reaction 
3 206 MeOH 10 50 199 
4     208 MeOH 100 100 199 
5 199 MeOH 100 100 no reaction 
6 206 EtOAc 10 50 no reaction 
7 206 EtOAc 20 50 no reaction 
8 206 EtOAc 50 25 no reaction 
9 206 THF 50 50 no reaction 
   10 206 EtOAc 50 100 over reduction 
11 206 EtOAc 50 50 over reduction 
12 206 EtOAc 30 50 no reaction 
 
Table 2.3 
 
                                                  
Figure 2.4 
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If 213 is the product, then cleavage of the ring must occur prior to 
hydrogenation of the double bond, as no reaction is observed when 210 is 
subjected to the same conditions (Scheme 2.38).   
                         
Scheme 2.38 
 
In light of these results it appeared that the catalyst and ligand choice were not 
suitable and so alternatives were considered. Rather than screen numerous 
combinations of catalysts and chiral ligands, it was decided that it would be 
appropriate to determine first that the required selective reduction could be 
achieved with an achiral homogeneous catalyst. Wilkinson’s catalyst 
[Rh(PPh3)3Cl]  and Crabtree’s catalyst ([Ir(COD)(PCy3)(Py)]PF6) were selected 
for this investigation. No reaction was observed when 208 was treated with 
[Rh(PPh3)3Cl] at 1 bar of hydrogen at room temperature, or when the pressure 
was increased to 50 bar (Table 2.4, entries 1 and 2). Upon heating to 50 OC, a 
complex mixture was obtained which contained no evidence for the presence of 
212 by either 1H NMR or mass spectroscopy (entry 3). Once again the mass 
spectrum contained evidence for a potential over-reduced product 214 (m/z = 
235, [M+H]+ + 2) but unfortunately we were unable to isolate this compound.  
Treatment of 208 with [Ir(COD)(PCy3)(Py)]PF6  gave similar complex mixtures, 
again displaying  mass spectrometry evidence for over-reduction,  even under 1 
bar of hydrogen (entries 4 and 5). 
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entry catalyst pressure 
(bar) 
time 
(h) 
temp. 
(oC) 
outcome 
1 [Rh(PPh3)3Cl] 1 16 25 no reaction 
2 [Rh(PPh3)3Cl] 50 16 25 no reaction 
3 [Rh(PPh3)3Cl] 50 16 50 over reduction 
4 [Ir(COD)(PCy3)(Py)]PF6 1 2 25 over reduction 
5 [Ir(COD)(PCy3)(Py)]PF6 1 0.5 25 over reduction 
 
Table 2.4 
 
 Based upon these results, it appeared that standard homogeneous 
hydrogenation catalysts were unsuitable for these substrates and so alternative 
asymmetric reduction methods were considered. Transfer hydrogenation 
reactions have found widespread use in the reduction of heterocycles, and so 
these conditions were investigated. Noyori-type reduction of 208 was attempted 
with a ruthenium/(R,R)-TsDPEN complex and formic acid as the hydride 
source.123 Unfortunately, complex mixtures of products were produced when the 
reaction was performed at 50 oC for 48 h, or at 25 oC for 12 h (Scheme 2.39). 
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For completeness, the reduction of the non-protected substrate 199 was also 
attempted. In this instance no reaction occurred and only starting material was 
observed in the crude 1H NMR spectrum (Scheme 2.40). 
                   
Scheme 2.40 
 
2.4 Conclusions 
During these studies we have successfully synthesised racemic 1,2-diamine 211 
via hydrogenation of phenyl-substituted imidazolinone 199 and subsequent 
hydrolysis with hydrochloric acid (Schemes 2.36 and 2.37). It was discovered 
that hydrogenation reactions of these compounds are highly sensitive to the 
nature of the nitrogen substituents, and we were able to demonstrate a dramatic 
increase in reactivity by regioselectively acetylating imidazolinone 199. 
Unfortunately, we were unable to extend this procedure to an asymmetric 
reduction.  It is unclear as to why the success of hydrogenation varies greatly 
between the catalysts and there may be a suitable asymmetric catalyst for such 
reactions. Nevertheless, considering the large number of catalyst and ligand 
combinations available as well as the precarious nature of the substrates it was 
concluded that our efforts should be focused elsewhere. Therefore we decided 
to investigate the use of related templates with exocyclic double bonds, as it was 
hoped this would circumvent at least some of the problems associated with the 
endocyclic analogues, particularly their high levels of aromatic character. 
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3.1 Introduction 
This chapter will discuss the use of nitrogen-containing heterocycles with an 
exocyclic double bond, such as 215, as templates for the synthesis of 1,2-
diamines. We envisioned that the location of the double bond outside of the ring 
would help circumvent the problems associated with the endocyclic analogues 
discussed in Chapter 2. In particular, issues arising from low reactivity due to 
aromatic character (imidazolinones) and difficulties of synthesis and stability 
(1,2-diazetines). The basic concepts and objectives of this investigation remain 
the same. Three key processes need to be developed to realise the goal. Firstly, 
the development of general methods for the functionalisation of the template, 
secondly, asymmetric reduction to install chirality into the substrate and finally 
deprotection to reveal the 1,2-diamine 218 (Scheme 3.1).         
                  
Scheme 3.1 
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It has already been suggested that imidazolidin-2-ones and 1,2-diazetidines are 
suitable candidates, as deprotection to a 1,2-diamine is expected to be 
straightforward. Therefore, we focused on the use of 
methyleneimidazolidinones 219 and methylenediazetidines 220 for the 
synthesis of 1,2-diamines (Figure 3.1).  
                                               
Figure 3.1 
 
Each heterocycle will be discussed in turn, beginning with background 
information from the literature regarding their synthesis and known reactions. 
Our own findings in relation to the synthesis of 1,2-diamines will then follow. 
 
3.2 Methyleneimidazolidinones 
3.2.1 Introduction 
Reports of both imidazolidinone and imidazolinone based compounds are 
abundant within the literature.104-108 These structures are found as part of natural 
products as well as a number medicinal compounds.6,124,125 However, 
imidazolidinones with an exocyclic double bond, particularly unsubstituted 
compounds, are far less common.  
 
3.2.2 Background 
In 2000 Lei and Lu reported the synthesis of a variety of imidazolidinones 222, 
lactams 223 and oxazolidinones 224 using a tandem intramolecular 
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aminopalladation of alkynes 221 with alkene insertion.126 The entire process 
allows the synthesis and functionalisation of the heterocycles in a single step 
(Scheme 3.2)    
 
  
Scheme 3.2       
 
Lei and Lu went on to demonstrate that 3-methyleneoxazolidinones 224 (X = O) 
could be hydrogenated with high enantioselectivities in the presence of a chiral 
rhodium catalyst (Scheme 3.3).127 Although hydrogenation of the corresponding 
3-methyleneimidazolidinones 222 (X = N) was not reported, the similarity of 
the compounds suggests such an asymmetric reduction might be feasible.  
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Scheme 3.3                                      
More recently, Padwa and co-workers have reported the cyclisation of N-(p-
toluenesulfonyl)-N’-(2-propyn-1-yl)urea (226) with AuCl3 to give 
imidazolidinone 227.128 No reactions of 227 have been reported, other than it 
slowly isomerises to trisubstituted alkene 228 under acidic conditions  (Scheme 
3.4). 
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Lu and Padwa have separately developed useful synthetic routes to 3-
methyleneimidazolidinones, which may be useful for our own studies. Lu’s 
synthesis allows for the formation and functionalisation of the ring in a single 
step, however the choice of functionalities introduced is somewhat limited. We 
therefore proposed utilising Padwa’s synthesis of 227; exploring the reactivity 
of the double bond and attempt to functionalise it using transition metal 
catalysed cross-couplings. In addition, Lu’s hydrogenation studies of 3-
methyleneoxazolidinones 224 provide us with a good indication of the 
feasibility of enantioselective reductions to 1,2-diamines, after further 
hydrolytic opening of the heterocycle.  
 
3.2.3 Reactions of N-tosyl-methyleneimidazolidinone 
Synthesis of N-tosyl-methyleneimidazolidinone 227 was carried out according 
to the procedure outlined in Scheme 3.4. It should be noted that what we 
assumed was 227 at this point was later determined to be 229. Characterisation 
of 229/227 shall be discussed later in the chapter, however we shall continue to 
use the true structure (229) from this point. We initially attempted cross-
coupling reactions between 229 and phenyl iodide under Heck conditions.129,130 
Even upon further heating to 110 oC, only starting material was recovered. We 
also examined the conditions used previously for the coupling of phenyl iodide 
with imidazolinone 185 (Scheme 2.29). Unfortunately, no reaction was 
observed in this instance (Scheme 3.5). 
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Scheme 3.5 
 
As initial palladium catalysed cross-couplings were proving unsuccessful, we 
decided to explore a different approach to functionalisation of the alkene 
terminus. Cross metathesis reactions with Grubbs I and II catalysts could 
provide a general route to such compounds.131,132 To test this idea, 1-octene was 
selected as an appropriate substrate due to its good reactivity in cross-
metathesis.133 However, use of either Grubbs I or II catalysts led only to 
formation of E-7-tetradecene (230) and recovery of 229 (Scheme 3.6) 
 
Scheme 3.6 
 
As a result of the apparent lack of reactivity of what was assumed to be 227 
towards metathesis, we considered bromination of the double bond and 
subsequent coupling with a boronic acid by way of Suzuki cross-couplings.  
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230
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                 Grubbs II
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Unfortunately, attempts to brominate the substrate with Br2 led to degradation 
of the starting material. No reaction was observed using NBS in place of 
bromine (Scheme 3.7). 
          
Scheme 3.7 
 
Whilst attempting to functionalise 229 with substituents on the exocyclic double 
bond, we also began preliminary hydrogenation studies on the parent substrate. 
The reaction was found to proceed under mild conditions with palladium on 
carbon to furnish 231 in a very modest 26% yield. This poor yield is due to two 
side products that were also isolated. The major side product was identified to 
be trisubstituted alkene 232, the data for which is consistent with published 
values for 228 (Scheme 3.4).128 The structure of the minor product was 
determined to be the ring-opened compound 233, based on mass spectrometry 
data as well as characteristic peaks for an n-propyl chain present in the 1H NMR 
spectrum (Scheme 3.8).  
    
Scheme 3.8 
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Since reduced compound 231 was found to be stable to the hydrogenation 
conditions, it would seem that over-reduced 233 is not derived from this 
compound. We therefore proposed 233 arises from initial C-N bond cleavage, 
followed by facile hydrogenation of mono-substituted alkene 234 (Scheme 3.9). 
No evidence for the presence of 233 could be seen in the crude reaction 
mixture, which would suggest that this reduction is relatively fast. 
  
        
Scheme 3.9 
 
We were fortunate enough to grow crystals of 231, from dichloromethane by 
evaporation, that were of suitable quality for X-ray diffraction. To our 
considerable surprise, this revealed the structure to be as described, rather than 
that of 235, which is what we were anticipating at the time  (Figure 3.2). 
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Figure 3.2 
 
This led us to reevaluate the gold-catalysed cyclisation of 226 reported by 
Padwa. The most likely explanation for this observation is that ring closure 
occurs through oxygen rather than nitrogen to afford 229 and not 227 (Scheme 
3.10). 
                     
                   
Scheme 3.10 
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As our spectroscopic data for 229/227 was identical to that of Padwa’s, we were 
quite confident that he had misassigned this cyclisation reaction. However, we 
could not rule out the possibility that rearrangement occurred during the 
palladium-catalysed hydrogenation. Therefore we felt it necessary to confirm 
the structure of 229 through an additional X-ray crystallographic analysis. 
Suitable crystals were grown from dichloromethane and we were able to 
confirm that the gold catalysed ring closure reported by Padwa does in fact 
yield oxazolidinimine 229. We believe that the N-tosyl group is aligned syn to 
N−H as this will allow for hydrogen bonding with one of the sulfonamide S=O 
groups (Figure 3.3). 
                          
Figure 3.3 
 
Interestingly, Padwa did propose ring closure of urea derivative 226 through 
oxygen as an alternative mechanism, but concluded that this did not occur 
(Scheme 3.11).128 This is presumably because he anticipated the tautomer 236, 
which did not match the 1H NMR data. One would expect to see an 
olefinic/aromatic peak for a single hydrogen, as well as a second methyl singlet 
to correspond to 236, whereas the observed peaks (Appendix 1), could be 
characterised as either 227 or 229. 
NHO
N Ts
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Scheme 3.11 
 
Although we were unable to obtain an X-ray structure for the endocyclic isomer 
232, our data was consistent with that of Padwa’s for 228. Therefore we believe 
there is sufficient evidence to show that the compound he proposed is also 
incorrect and instead has the structure 232 (Figure 3.4). 
   
Figure 3.4 
 
The structure of the over-reduced compound 233 is as we initially proposed, as 
the product from the over-reduction of 229 will likely tautomerise to the 
corresponding urea 233 (Scheme 3.12). 
 
 
Scheme 3.12 
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Upon consulting the literature for similar reactions it was discovered that Toste 
and Campbell have recently reported the synthesis of cyclic carbamimidate 239 
in the presence of a monophosphine gold(I) catalyst.134 It is reported that ring-
closure occurs through the oxygen atom and is thus fully consistent with our 
own findings (Scheme 3.13). 
 
Scheme 3.13 
 
Although Toste and Campbell have also reported an X-ray structure for an 
analogue of 239, and thus also confirming ring closure through oxygen, there 
has not to our knowledge, been any link made between these results and those 
reported by Padwa. In addition, the variation in substrate, catalyst and reaction 
conditions show that Toste’s results alone cannot be used as conclusive 
evidence against the findings of Padwa’s. It is therefore believed that our 
findings will help remove any ambiguity regarding the gold catalysed ring 
closure of propargyl urea derivatives.  
 
It is not certain why ring-closure of 226 occurs preferentially through oxygen. 
However, based on work by previous group member Mike Brown, it has been 
shown that ring-closures involving ambident carbamate nucleophiles for the 
synthesis of 1,2-diazetidines are particularly sensitive to the electronic nature, or 
the “hardness” of the leaving group, as described by Pearson’s Hard Soft Acids 
and Bases (HSAB) principle.90,135 Dr. Brown demonstrated that altering the 
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leaving group had a profound effect on the cyclisation of 241, with either 1,2-
diazetidine 242 or 243 afforded as the major product, depending on the leaving 
group R. The structures of both 242 and 243 have been confirmed by X-ray 
crystallography (Scheme 3.14).137 
 
 
Scheme 3.14 
 
These observations would suggest that the coordination of AuCl3 to alkyne 226 
creates a “hard” electrophile that favours ring-closure through oxygen, as 
previously described in Scheme 3.10. 
 
It would be of interest to determine whether or not this preference for closure 
through oxygen rather than nitrogen is witnessed in other, non-gold catalysed 
reactions. For instance, one could imagine a similar preference for ring closure 
through oxygen with the reactions reported by Lu (Scheme 3.15).126 
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Scheme 3.15 
 
It was hoped that we could compare our 13C NMR data for 229 with that of Lu’s 
for methyleneimidazolodinone 222, as it was believed the shift of the peak 
corresponding to C-2 in 229 and 222 would aid us in determining if Lu’s 
structure is correct (Figure 3.4).  
                                  
Figure 3.4 
 
Unfortunately no 13C NMR data was published with Lu’s report. However, his 
more recent paper, which demonstrates the hydrogenation of 
methyleneoxazolidinones, reports the hydrolysis of 245 to yield N-tosyl amino 
alcohol 246.127 If the palladium-catalysed ring closure occurred through oxygen 
to afford 247, then subsequent hydrolysis would be expected to give 1,2-diol 
248 (Scheme 3.16).  Differentiation between 246 and 248 should be trivial by 
NMR and mass spectroscopy and there should be no ambiguity regarding the 
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charaterisation of the product. Indeed, Lu’s spectroscopic data is in accordance 
with other published data for 246.136 
       
Scheme 3.16 
 
3.2.4 Conclusions 
Whilst investigating the use of 227 as a potential template for the synthesis of 
1,2-diamines, we determined by X-ray crystallography that the structure for 227 
reported in the literature was in fact incorrect, and that the true structure is that 
of 229. Based on these findings we can now summarise the reactions that have 
actually been attempted (Scheme 3.17). Whilst were able to hydrogenate 229 
with palladium on carbon, all other attempts to functionalise it were 
unsuccessful. Although the electronic nature of the double bond in 229 will be 
different to what was originally anticipated, its lack of reactivity is still 
surprising.  
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Scheme 3.17 
  
Once the true structure of 229 had been established, it was evident that this was 
not a suitable template for the synthesis of 1,2-diamines. The inability to 
functionalise 229 through palladium or ruthenium catalysed C−C bond forming 
processes therefore became irrelevant. It is possible that if a synthetic route to 
methyleneimidazolidinones could be found, it may prove to be a useful 
template. However, disheartened by the misleading literature in this area we 
decided to explore an alternative template.  
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3.3 3-Methylene-1,2-diazetidines 
        3.3.1 Introduction 
Recently Shipman et al. reported the synthesis of 3-methylene-1,2-diazetidines 
from 2-haloallyl alcohols.100 For example, synthesis of 251 is achieved with a 
reductive coupling of alcohol 249 with diethylazodicarboxylate followed by 
copper-catalysed ring closure  (Scheme 3.18). 
 
 Scheme 3.18 
 
This efficient, 2-step synthesis gives excellent yields and the ring closing 
reaction has been shown to work for a variety of substrates including 252-257 
(Figure 3.5). 
                  
         Figure 3.5 
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Due to the novelty of these compounds, their chemistry is still largely 
unexplored. Nevertheless Shipman et al. have already demonstrated that 
unfunctionalised 3-methylenediazetidines 251 and 252 can undergo Heck 
reactions with aryl iodides. Although the reported yields are low, the reaction 
shows excellent diastereoselectivity, with the E isomer being the major product 
(Scheme 3.19).100 
 
Scheme 3.19  
 
Mike Brown has also shown that cyclopropanation of 254 produces expanded 
cyclopropane 261.137 To account for this finding, it was proposed that a second 
equivalent of the zinc carbenoid inserts into the N−N bond (Scheme 3.20).   
                       
Scheme 3.20 
 
Although this reaction was somewhat unexpected, it is consistent with a 
reaction reported by Taylor and Davis, who observed a similar insertion whilst 
attempting a rhodium catalysed ring closure to β-lactam analogues  (Scheme 
3.21).138 
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Scheme 3.21 
 
Other efforts by Mike Brown to functionalise 251 were less successful. For 
example, Grubbs metathesis with 1-octene led only to starting material and E-7-
tetradecene (229) (Scheme 3.22).137 
            
                          
Scheme 3.22 
 
Reactions with 3-methylene-1,2-diazetidine 255 were also briefly explored, as it 
was expected to be a potential substrate for Suzuki and Negishi couplings. 
Unfortunately this was not the case and only starting material was recovered in 
both instances. Chlorides are generally less reactive in cross-couplings and this 
presumably accounts for the lack of success in these processes (Scheme 3.23).139 
                        
        Scheme 3.23 
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Preliminary hydrogenation studies of methylenediazetidines were also 
undertaken. Bicycle 257 was easily hydrogenated to diazetidine 262 under 
standard palladium on carbon conditions with excellent yield. It was deduced 
that this reaction proceeded to give exclusively the syn product. Subsequent 
reduction of 262 with LiDBB provided the protected diamine 263 in good yield 
(Scheme 3.24).100 
 
                   
Scheme 3.24 
 
Although the chemistry of 3-methylene-1,2-diazetidines is still largely 
unexplored, the preliminary results suggest that this class of compounds could 
prove ideal for the development of a general route to 1,2-diamines. 
Functionalisation of unsubstituted methylenediazetidines through Heck 
reactions has been demonstrated. Hydrogenation of bicycle 257 and subsequent 
cleavage of the N−N bond to yield carbamate-protected 1,2-diamine 263 has 
also been achieved.  We wished to utilise the known Heck chemistry as well as 
explore other methods of functionalisation to provide a range of substituted 3-
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methylene-1,2-diazetidines 265. The asymmetric hydrogenation of these 
substrates followed by N−N bond cleavage to yield a range of enantiomerically 
enriched 1,2-diamines 267 could then be investigated (Scheme 3.25).     
                     
Scheme 3.25 
 
3.3.2 Functionalisation of 3-methylene-1,2-diazetidines  
It has already been shown that 3-methylene-1,2-diazetidines are able to undergo 
Heck-type reactions with aryl iodides, albeit in modest yields (Scheme 3.19).100 
In addition, it is possible to incorporate certain functionalities prior to ring-
closure. This however is considered an undesirable method, as the synthesis of 
the precursor itself then requires several steps, as illustrated for the synthesis of 
alkene 268 (Scheme 3.26).137 
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Scheme 3.26 
 
As a result, we decided to investigate alternative methods for the 
functionalisation of 3-methylene-1,2-diazetidines. In turn, this would provide us 
with a variety of suitable substrates for hydrogenation studies.  
 
Following the route outlined in Scheme 3.18, known 3-methylene-1,2-
diazetidines 251 and 252 were synthesised. In addition, the novel derivatives 
273 and 274 were prepared, as this would provide us a broader range of 
substrates to investigate (Scheme 3.27). 
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Scheme 3.27 
 
The Heck reaction reported by Shipman and co-workers (Scheme 3.19) was 
then used to make 258 and 260, as well as new methylenediazetidines 275 and 
276 (Scheme 3.28).100 Yields were modest in each case, however it was found 
that lowering the reaction temperature to 70 oC gave the E-isomer of the 
products exclusively. This was confirmed for 258 by comparing 1H NMR data 
with that of Mike Brown’s, who has assigned the structure by X-ray 
crystallography. It is believed the same stereoselectivity applies to 260, 275 and 
276, due to the similarity of the 1H NMR spectra. The distinct difference (0.42 
ppm) in chemical shift for the two terminal ethyl triplets in Z-258 is not 
witnessed in 260, 275 or 276. 
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Scheme 3.28 
 
Previous attempts to perform cross coupling reactions with diethyl 3-
(chloromethylene)-1,2-diazetidine (255) were unsuccessful (Scheme 3.23). 
However, we believed that the corresponding bromide would prove more 
reactive in Suzuki couplings. This approach could nicely complement the 
existing Heck process and allow for the synthesis of a wider range of substrates, 
in part, because of the wide range of available boronic acids.  
 
Reaction of 251 with Br2 and DBU was initially unsuccessful, as only 
degradation of the starting material was observed (Table 3.1, entries 1 and 2). 
Addition of the reagents at −78 oC yielded a complex mixture, which contained 
no evidence for 277 (entry 3). Changing the base to triethylamine made no 
improvement (entry 4). Allowing the mixture to warm to room temperature 
before the base was added also led to degradation (entry 5).  However, 277 was 
eventually obtained after allowing the reaction mixture to warm to −50 oC 
before the addition of DBU and then keeping the temperature constant for 4 h. 
This allowed us to isolate 277 in 42% yield as a single isomer (entry 6). Traces 
of what is believed to be the other isomer of 277 were observed, however we 
did not isolate it in a pure state. Attempts to improve upon this yield by adding 
DBU at different temperatures were unsuccessful (entries 7 and 8). It is also 
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important to note that this reaction was rather difficult to perform 
experimentally, and it was highly irreproducible. 
                         
entry time A1 
(h) 
temp. X 
(oC) 
base time B1 
(h) 
temp. Y    
(oC) 
Outcome  
1 1 0 DBU 4 25 degradation 
2 1 0 DBU 1 0 degradation 
3 1 -78 DBU 4 -78->25 mixture 
4 1 -78 Et3N 4 -78->25 mixture 
5 1 -78->25 DBU 4 25 degradation 
6 1 -78->-50 DBU 4 -50  277 (42%) 
7 1 -78->-60 DBU 4 -60  277 (12%) 
8 1 -78->-40 DBU 4 -40 277 (7%) 
 
Table 3.1. 1Time the reaction was maintained at the corresponding temperature. 
 
The geometry of 277 is not certain. However, the difference in shift of the 
triplets corresponding to the two terminal ethyl hydrogens in the 1H NMR 
spectrum of 277 is very small (0.03 ppm). Based on the observed shifts for the 
analogous hydrogens in E-258 (1.38, 1.33 ppm) and Z-258 (1.36, 0.94 ppm), 
one would expect a bromine in the Z position to have a more profound effect on 
these shifts in 277. Tentatively, this would suggest that in this case it is the E 
isomer of 277 that has been obtained. 
 
 
The synthesis of 277 was also achieved with N-bromosuccinimide (NBS), 
however this also led to a complex mixture of products and 277 was only 
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obtained in very low yield. Lowering the reaction temperature led to only traces 
of product (Scheme 3.29). 
                 
Scheme 3.29 
 
It had initially been hoped that the bromination and subsequent coupling of 277 
with an appropriate boronic acid would allow us to synthesise functionalised 
methylenediazetidines in good yields. Unfortunately, as the bromination step 
was proving to be particularly difficult, this route did not appear to be suitable. 
Nevertheless, the Suzuki coupling of 277 and phenyl boronic acid afforded E-
258 in 50% yield without optimisation (Scheme 3.30).140 1H NMR data for this 
reaction was consistent with that of E-258 obtained from the Heck reaction 
(Figure 3.6), confirming the geometry is the same. However this does not prove 
the geometry of 277, as Suzuki has shown that this reaction does not necessarily 
proceed with retention at the vinyl halide position.141 Therefore we can only 
speculate that this reaction proceeded with retention of stereochemistry based 
on the 1H NMR data, as previously discussed.   
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3.3.3 Hydrogenation Studies of 3-Methylene1,2-diazetidines 
Shipman and co-workers have previously reported that hydrogenation of 
dibenzyl 7,8-diazabicyclo[4.2.0]oct-1-ene-7,8-dicarboxylate (257), proceeds 
smoothly under heterogenous hydrogenation conditions (Scheme 3.24).100 We 
wished to investigate the enantioselective hydrogenation of the functionalised 
methylenediazetidines 258, 260, 275 and 276. To do this, the use of chiral 
homogenous catalysts would most likely be required. Although the chemistry of 
3-methylene-1,2-diazetidines is still largely unexplored, there are a number of  
examples in the literature for the asymmetric hydrogenation of related systems 
that proceed with excellent enantioselectivity. Lu’s work, which has been 
discussed previously (Scheme 3.3), involves the hydrogenation of structures 
that share a number of similarities with 3-methylene-1,2-diazetidines, namely 
nitrogen containing heterocycles with exocyclic double bonds.127 In addition, 
there is a lot of research into the enantioselective hydrogenation of enamides.142 
For example, Zhang and co-workers have demonstrated the asymmetric 
hydrogenation of a variety of enamides 278 with excellent enantioselectivities 
using a rhodium catalyst and (R,R)-BICP (Scheme 3.31).143 Although it is still 
unclear as to how chemically similar the double bond of a 3-methylene-1,2-
diazetidine is to that of an enamide,  we believe that such examples provide a 
good indication of the feasibility of the asymmetric hydrogenation of such 
systems. 
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Scheme 3.31 
 
As the only previous example for the hydrogenation of a methylenediazetidine 
involved strained bicycle 257 (Scheme 3.24), we felt it necessary to investigate 
the hydrogenation of unfunctionalised methylenediazetidine 251 with palladium 
on carbon as catalyst before exploring the large variety of chiral homogeneous 
catalysts that are available. The reaction proceeds slowly in ethyl acetate to give 
a mixture of desired product 280, as well as the over-reduced product 281 
(Table 3.2 entry 1). Switching the solvent to methanol increases the rate of 
reaction but also that of over-reduction (entry 2). Using triethylsilane as a 
hydrogen source proved to be a convenient alternative to a hydrogen balloon, as 
it offered faster reactions without compromising yields or selectivity (entries 3 
and 4).144 Under the most effective conditions (entry 4) the reduced 1,2-
diazetidine 280 was isolated in 70% yield.  
 
 
 
 
 
R
Ar NHAc Ar NHAc
+
R
Ar NHAc
R
[Rh(COD)2]OTf
(R,R)-BICP, PhH
 H2, 40 bar, 25 oC
85-95% ee
R = H, Me, Et, Bn
H
H
PPh2
Ph2P
(R,R)-BICP
Z-278 E-278 (R)-279
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 H2 source catalyst solvent Time (h) 280 (%) 281 (%) 
1 H2 (1Bar) Pd/C EtOAc 24  68 5 
2 H2 (1Bar) Pd/C MeOH 16  54 23 
3 Et3SiH PdCl2 EtOH 2  62 29 
4 Et3SiH PdCl2 EtOAc 4  70 4 
 
Table 3.2.  
 
 
Characterisation of the two products was straightforward using NMR and mass 
spectroscopy techniques. A doublet in the 1H NMR spectrum of 280, 
corresponding to the exocyclic methyl group, as well as one new ring hydrogen, 
were diagnostic in its characterisation. The over-reduced product 281 displayed 
two extra mass units in the mass spectrum as well as a characteristic n-propyl 
pattern in the 1H NMR spectrum, similar to that of 232 (Scheme 3.8). This was 
mildly surprising, as we expected any over-reduction that might have occurred 
would involve cleavage of the N−N bond. However, based on the 1H NMR data, 
this was clearly not the case. 
 
Next the hydrogenation of the phenyl-substituted methylenediazetidine 258 was 
investigated. Under a balloon of hydrogen, the reaction was found to be 
extremely slow, and even after three days only traces of 282 and 283 were 
observed. However, the use of triethylsilane again proved effective, enabling 
the reaction to go to completion within 8 hours. Unfortunately, the presence of 
N N
CO2EtEtO2C
251
N N
CO2EtEtO2C
280
HN N
CO2EtEtO2C
281
+
H2, 25 oC
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the phenyl substituent lead to increased quantities of over-reduction (Scheme 
3.32).   
 
Scheme 3.32 
 
The occurrence of this increased over-reduction may have arisen for either 
electronic or steric reasons. Clearly the double bond of 258 is more hindered 
than that of parent 251 and so palladium will not coordinate as easily, whereas 
C−N bond insertion, leading to over-reduction to 283, would be less affected by 
the presence of the phenyl substituent. From an electronic viewpoint, the 
presence of the phenyl substituent on 258 may simply alter the electronics of the 
system in a way that increases the lability of the C−N bond. 
 
 
Before turning our attention to chiral catalysts, we wished to attempt a 
hydrogenation with Wilkinson’s catalyst. As many asymmetric hydrogenation 
complexes are based on homogeneous rhodium complexes, we believed a 
hydrogenation with Wilkinson’s catalyst would offer some initial insights into 
the reactivity of these chiral catalysts. No reaction occurred at 1 bar, although 
this was not altogether unexpected, and the reaction was found to proceed under 
higher temperature and pressure. Although the yield for the reaction is modest, 
N N
CO2EtEtO2C
Ph
N N
CO2EtEtO2C
Ph
HN N
CO2EtEtO2C
Ph
   Et3SiH, PdCl2
EtOAc, 25 oC, 8 h
258 282
36%
283
28%
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we were pleased to observe that under these conditions, problems of over-
reduction were avoided (Scheme 3.33).  
                  
Scheme 3.33 
 
We began our study into the asymmetric hydrogenation of 
methylenediazetidines with the [Rh(NBD)2]BF4 catalyst and the Josiphos ligand 
that we used initially for the attempted hydrogenation of phenylimidazolinone 
210 (Scheme 2.38). Under the same conditions used previously, (R)-280 was 
obtained in 89% yield and an encouraging 44% ee. The assignment of the 
absolute stereochemistry of 280 will be discussed later in this chapter (Scheme 
3.34). 
 
Scheme 3.34 
 
Determination of the enantiomeric purity of 280 was achieved with HPLC 
analysis using a Chiralcel AD column (5% iPrOH/n-hexane; 1.0 mL/min; 220 
N N
CO2EtEtO2C
251
N N
CO2EtEtO2C
280
H2, [Rh(PPh3)3Cl]
  CH2Cl2, 50 oC
     5 h, 50 bar
56%
N N
CO2EtEtO2C
251
N N
CO2EtEtO2C
    (R)-280
89%, 44% ee
HN N
CO2EtEtO2C
281
 8%
+
FeP
Ph
Ph P Cy
Cy
Josiphos
J001-1
H2, [Rh(NBD)2]BF4
   J001-1, EtOAc
50 oC, 5 h, 50 bar
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nm) to reveal an ee of 44% [tR = 22.19 min (major), 24.74 (minor)]. A racemic 
sample of 280 obtained from the previous reaction with Wilkinson’s catalyst 
(Scheme 3.33) was used as a standard in this analysis.  
 
Encouraged by this result, we examined the variation of the metal source and 
reaction conditions with this Josiphos ligand. Changing the solvent to methanol 
led to decreased enantioselectivity, as well as preference for the S enantiomer 
(Table 3.3, entry 1). Lowering the temperature to 30 oC was found to eliminate 
the formation of 281 as well as increase the enantioselectivity of 280 to 61% 
(entry 2). However, the rate of reaction was significantly reduced and starting 
material was mostly recovered. Using dichloromethane as the solvent under the 
same conditions resulted in both a loss in rate and enantioselectivity (entry 3). 
Finally switching the metal source to [Rh(COD)Cl]2 was found to give slightly 
lower enantioselectivities but also further decreases in the rate of reaction 
(entries 4 and 5).  
 
entry catalyst solvent temp (oC) 280 
(%) 
281 
(%) 
ee (%) 
1 [Rh(NBD)2]BF4 MeOH 50 63 10 4 (S) 
2 [Rh(NBD)2]BF4 EtOAc 30 28 0 61 (R) 
3 [Rh(NBD)2]BF4 CH2Cl2 30 8 0 53 (R) 
4 [Rh(COD)Cl]2 EtOAc 30 2 0 58 (R) 
5 [Rh(COD)Cl]2 CH2Cl2 30 8 0 49 (R) 
 
Table 3.3 
 
N N
CO2EtEtO2C
251
N N
CO2EtEtO2C
HN N
CO2EtEtO2C
+
H2, catalyst, J001-1solvent, 5 h, 50 bar
280 281
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Having concluded that our first choice of catalyst and solvent appeared to be the 
most suitable, we applied these conditions to the hydrogenation of 252, as we 
wanted to explore what effect (if any) the bulkier tbutyl groups would have on 
enantioselectivity. Hydrogenation of 252 proceeded in slightly lower yield than 
251, but we were pleased to observe an ee of 60% at 50 oC with no evidence of 
over-reduction (Scheme 3.35).  
                        
Scheme 3.35 
 
 
In addition, we also wished to investigate how effective these conditions were 
for the enantioselective hydrogenation of substituted methylenediazetidines, 
such as 258. The presence of a phenyl substituent was found to decrease the rate 
of hydrogenation significantly, as only a trace of product was observed after 5 
h. Increasing the reaction time to 72 h allowed us to isolate 282 in 54% with 
33% ee (Scheme 3.36). 
 
Scheme 3.36 
 
 
Following on from these initial results, we turned our attention to variation of 
the chiral ligand with a view to improving the enantioselectivites. For the 
purposes of the study, methylenediazetidine 251 was chosen as the substrate. 
N N
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Although higher enantioselectivies would likely be obtained at lower 
temperatures, for convenience, ligand screening was conducted at 50 oC in order 
to get good conversions (Scheme 3.37). 
                           
Scheme 3.37 
 
To begin with, other Josiphos ligands were investigated (Figure 3.6), followed 
by other ferrocene-based complexes Walphos and Taniaphos (Figure 3.7). 
Members of the Mandyphos family of ligands were found to be particularly 
promising (Figure 3.8). These ligands are all produced by SolviasTM and are 
commercially available. Finally, three ligands based on the more conventional 
BINAP type structure were investigated (Figure 3.9). 
 
Figure 3.6 
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Figure 3.7 
 
 
  
 
Figure 3.8 
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Figure 3.9 
 
Following this investigation, it was quite apparent that Mandyphos M004-1 was 
the best ligand for the hydrogenation of methylenediazetidine 251, offering both 
excellent yield (98%) and enantioselectivity (89% ee). Of the ligands screened, 
M004-1 would appear to be the most bulky, this presumably limits the 
orientation with which 251 can coordinate to the catalyst and so increases the 
preference for one face over another.  
 
Hydrogenation of other methylenediazetidines was then investigated with these 
reaction conditions, as it was hoped Mandyphos M004-1 would prove to be a 
ligand of broad scope for this asymmetric transformation. Unfortunately this 
was not the case, and the enantioselectivities with substituted 
methylenediazetidines were considerably lower. It should be noted that we were 
only able assign absolute stereochemistry of 280 based on the study in the next 
section (3.3.4), therefore the configurations of the other substrates 282, 284-287 
are unknown (Table 3.4). 
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entry substrate R1 R2 temp 
(oC)  
time 
(h) 
product  ee (%)i 
1 251 Et H 50 5 280 (98%) 89 (S) 
2 251 Et H 30 72 280 (98%) 88 (S) 
3 252 tBu H 50 5 284 (52%) 52 
4 258 Et Ph 50 72 282 (89%) 8 
5 276 Et C6H4tBu 50 72 285 (58%) 19 
6 275 Et Naphthyl 50 72 286 (55%) <30 
7 260 Et C6H4OMe 50 72 287 (34%) 18 
 
Table 3.4 i Determined by chiral HPLC (Appendix 5) 
 
 
It is unclear why enantioselectivity decreases for substituted 
methylenediazetidines with M004-1. The decrease in rate of hydrogenation 
observed for these sterically hindered substrates (Scheme 3.36) suggests that 
they are unable to bind as effectively to the catalyst as 251 and this weaker 
coordination could be less facially selective.  M004-1 has been shown to be an 
excellent ligand for other tri-substituted alkenes, such as 288 (Scheme 3.38).145 
Hydrogenation of 288 was successful under far milder conditions than we have 
been able to achieve with our substrates. This may be due to the carbonyl group 
adjacent to the double bond in 288, which most likely chelates to the rhodium 
catalyst and increases the rate. Presumably this coordination also leads to better 
facial selectivity. 
N N
CO2R1R1O2C
NN
CO2R1R1O2C
    50 Bar
        H2, [Rh(NBD)2]BF4
  Mandyphos M004-1, EtOAc
R2 R2
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Scheme 3.38 
 
Due to time constraints we were unable to continue to investigate other catalyst 
and ligand combinations for the substituted derivatives.  Nevertheless it is 
believed that further study could lead to identification of ligands for the 
enantioselective hydrogenation of a wide range of methylenediazetidines to 1,2-
diazetidines.  
 
 
3.3.4 N–N bond cleavage and assignment of stereochemistry 
 
Diazetidines 280 and 282 were reductively cleaved with LiDBB to yield the 
corresponding carbamate-protected 1,2-diamines (Scheme 3.39).100   
          
Scheme 3.39 
 
To ascertain the absolute stereochemistry of 280 produced in the asymmetric 
hydrogenations, we prepared authentic samples of 290 in racemic and 
enantiomerically enriched forms from commercially available (±) and (R)-1,2-
diamino propane (292) and ethyl chloroformate (Scheme 3.40) 
Ph
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291 (R = Ph) 69%
LiDBB, THF
 78 oC, 1 h
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Scheme 3.40 
 
Diamine 290 possesses very little UV activity; making chiral HPLC detection 
difficult. The enantiomers could not be resolved by chiral HPLC on a Chiralcel 
AD column or by gas chromatography using a Chrompak CP-Chirasil Dex Cβ 
column. However, 1H NMR analysis of (±)-290 in d6-benzene in the presence of 
William H. Pirkle’s alcohol (S enantiomer) allowed us to resolve the doublet, 
corresponding to the methyl group at C-3, into two separate peaks.146 Spiking 
the 1H NMR sample with an equivalent amount of (R)-290 enabled us to 
determine that by the increased integration of the upfield signal, this peak 
corresponded to the R enantiomer. 1H NMR analysis of 290, obtained by 
reduction with LiDBB (Scheme 3.39) with Pirkle’s alcohol resulted in 
resolution with the predominant peak being the downfield signal. Thus, we were 
able to determine that asymmetric hydrogenation of 251 with Mandyphos 
M004-1 is selective for the S enantiomer (Figure 3.10). Furthermore, integration 
of the resolved doublets were found to give 89% ee, this indicates that the 
LiDBB reduction causes no racemisation, as the ee is equal to that of the 
starting 1,2-diazetidine 280 (Appendix 2). 
 
H2N NH2
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EtO2CHN NHCO2Et
(±)-290
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THF, 70 oC, 4 h
63%
NH2H2N
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EtO2CHN NHCO2Et
(R)-290
>99% ee
 EtOCOCl, Cs2CO3
THF, H2O 70 oC, 4 h
99%
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Figure 3.10 
 
In summary we have demonstrated an efficient two-step synthesis of protected 
1,2-diamine 290 from methylenediazetidine 251 with good yields and excellent 
enantioselectivity (Scheme 3.41). 
                
Scheme 3.41 
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3.3.5 Other reactions of 3-methylene-1,2-diazetidines 
In other studies, we have further explored the chemistry of the exocyclic double 
bond of these substrates. We began our investigations with the Diels-Alder 
cycloaddition reaction. The electronic nature of the methylenediazetidine is not 
fully understood, although the 1H NMR for the two olefinic hydrogens (4.94 
and 4.40 ppm in CDCl3) would indicate a relatively electron neutral double 
bond. We began using 1,3-cyclopentadiene, which is known to be a highly 
reactive diene, providing good yields of cycloadducts with a wide range of 
electron-deficient dienophiles.147 Methylenediazetidine 251 was heated with 5 
equivalents of freshly cracked 1,3-cyclopentadiene in a sealed tube at 150 oC.  
Unfortunately, only starting material and cyclopentadiene dimer were recovered 
from this reaction (Scheme 3.42). 
             
Scheme 3.42 
 
The lack of reactivity with 1,3-cyclopentadiene suggests that the double bond of 
251 is not electron-deficient and that an inverse electron demand Diels-Alder 
reaction might be more appropriate.148 Thus, cycloaddition with the electron-
deficient diene, ethyl sorbate was attempted. No reaction was observed at room 
temperature, or when heated to 100 oC (Scheme 3.43). 
         
Scheme 3.43 
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Next, 1,3-dipolar cycloadditions were explored. The azomethine ylide 293 
(generated in situ from sarcosine ethyl ester and paraformaldehyde) was found 
to react with methylenediazetidine 251 to yield a complex mixture of 
compounds, alongside large quantities of unreacted starting material.149 A peak 
corresponding to either 294 or 295 was present in the crude mass spectrum (m/z 
= 366, [M+Na]+), however all attempts to isolate 294 by column 
chromatography were unsuccessful and only more complex mixtures were 
obtained, with no conclusive peaks identified in the corresponding 1H NMR 
spectra (Scheme 3.44).    
 
Scheme 3.44 
  
Cycloaddition reactions with nitrile oxides were also explored. It was believed 
that reaction of 251 with phenyl nitrile oxide (296) would furnish one of the two 
spirocyclic regioisomers 297 or 298 (Scheme 3.45).150  
 
Scheme 3.45 
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296 was formed in situ by the deprotonation of 299, which subsequently reacted 
with 251 to form unidentified product 300 (Scheme 3.46).  
          
Scheme 3.45 
 
Unknown product 300 possessed the correct mass for both 297 and 298 (m/z = 
356 [M+Na]+), however the 1H NMR spectrum was not convincing.  Peaks 
corresponding to the phenyl ring, two ethyl chains, and what was initially 
thought to be two diazetidine ring hydrogens were present, but the remaining 
two hydrogens appeared far further downfield than one would expect in either 
of the expected products (Appendix 3). Based upon this NMR data, we 
proposed that reaction of 251 with phenyl nitrile oxide initially forms 297, 
which then undergoes ring-opening followed by aromatisation to afford 
isoxazole 300 (Scheme 3.47). 
 
Scheme 3.47 
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As it is unlikely that 298 would be able to undergo this ring-opening process, it 
is believed that 300 is the correct regioisomer for this reaction.  
 
The same reaction was attempted with methylenediazetidine 274, as the 
intermediate would be unable to aromatise and so the spirocyclic intermediate 
may be obtained. However, no reaction was observed with this highly hindered 
substrate, and the starting material remained unchanged (Scheme 3.48).  
  
Scheme 3.48 
 
In other chemistry, tetracyanoethylene was found to react with a number of 
methylenediazetidines under mild conditions to yield the novel, spirocyclic 
diazetidines 301-304.152 The tetra-substituted alkene 274 proceeded in low 
yield, although this was not unexpected due to the steric hindrance of the double 
bond (Scheme 3.49). 
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Scheme 3.49 
 
These compounds were isolated as stable crystalline solids and we were able to 
obtain an X-ray structure of 303 that clearly reveals the intriguing spirocyclic 
structure (Figure 3.11). 
                                    
Figure 3.11 
 
Mike Brown had previously attempted epoxidation of 254 with m-CPBA.137 
However, this led to ring-opened product, either 306 or 307, which is expected 
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to arise from attack of the carboxylate onto the initially formed epoxide 305  
(Scheme 3.50). 
 
Scheme 3.50 
 
Although epoxide 305 was not obtained, the presence of the ring-opened 
compound suggests that its formation does occur. We therefore decided to 
investigate epoxidation with milder conditions. DMDO was selected as an 
oxidising agent, as no nucleophilic side-products are produced.153 The reaction 
was found to proceed easily under mild conditions to give epoxide 308 in 
excellent yield. Mass spectroscopic analysis of 308 revealed it to have the 
correct mass (m/z = 253 [M+Na]+) and the 1H NMR spectrum displayed four 
doublets corresponding to the four ring hydrogens (Appendix 4). The 
spirocyclic compound was found to be quite unstable, rapidly degrading on 
silica gel, or within several days when stored under nitrogen. Fortunately, the 
reaction was sufficiently clean that the product could be isolated without the 
need for purification (Scheme 3.51). 
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Scheme 3.51 
 
The conditions used for the epoxidation of 251 were also applied to diazetidines 
252, 273 and 274. Based on crude 1H NMR and mass spectroscopy data, the 
reactions are believed to have been successful. However the desired compounds 
were not produced cleanly, and we were unable isolate them due to their 
instability.  
 
Compounds containing cyclopropane rings are prominent in a wide range of 
natural products and many possess biological activity.154 Noranthroplone (309) 
for example, exhibits cytotoxicity against B-16 melanoma cells whereas (+)-E-
chrysanthemic acid (310) is a potent insecticide (Figure 3.12).155,156 
                      
Figure 3.12 
 
With this mind, we thought that the cyclopropanation of substituted 
methylenediazetidines would provide a potentially useful synthetic route to a 
variety of novel functionalised 1,2-diamino cyclopropane products. The 
cyclopropanation of methylenediazetidine 254, which also leads to unexpected 
carbenoid insertion into the N–N bond, has already been reported (Scheme 
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3.20).137 It was expected however, that compounds such as 261 should be 
capable of hydrolysis under aqueous acidic conditions. This would provide an 
alternative route to the corresponding 1,2-diamines compared to direct N−N 
bond cleavage as previously discussed. Cyclopropanation of 251 led to the 
expected product 311, although all attempts to purify it led to degradation. 
Therefore it was hydrolysed directly with hydrochloric acid to 312, tentatively 
assigned based on the 1H NMR spectrum, which possesses a broad singlet at 
0.83 ppm, integrating to four hydrogens, which is assigned to the cyclopropane 
ring. In addition, mass spectroscopic data are in accordance with the structure 
(m/z = 253 [M+Na]+) (Scheme 3.52).   
      
Scheme 3.52 
 
The low yield for this reaction likely arises from the first step not going to 
completion, as there is a significant amount of starting material still present in 
the crude 1H NMR spectrum. Increasing the reaction time (3 days) and 
equivalents of diethyl zinc and diiodomethane (10 eq. of each) did not help 
drive the reaction to completion. The cyclopropanation of 258 was then 
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attempted, however no product was observed and only starting material was 
recovered.  Increasing the reaction temperature did not yield any of expected 
product 313 (Scheme 3.53). Unfortunately due to time constraints, we were 
unable to pursue this chemistry further. 
          
Scheme 3.53 
 
3. 4 Conclusions and Future Work 
We have identified conditions for the asymmetric synthesis of 1,2-
diaminopropane, with high ee, via a two-step process. This method has been 
extended to other substrates, however the enantioselectivies are lower. For 
example, with phenyl substituted 258, the ee fell to 33% with Josiphos J001-1 
(Scheme 3.36). We have been successful in widening the scope of the Heck 
coupling reaction (Scheme 3.28) and demonstrating the first Suzuki coupling 
with bromide 277. The first examples of [2+2] (Scheme 3.49) and [2+3] 
(Scheme 3.47) cycloadditions of 251 have been realised. Taken together with 
the lack of reactivity with both electron-rich and electron-poor dienes in Diels-
Alder reactions, these suggest that the double bond of these substrates is 
essentially electronically neutral. In addition, we have achieved the first 
epoxidation of 3-methylene-1,2-diazetidine (Scheme 3.54).  
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Scheme 3.54 
 
 Although the Heck coupling proceeds with modest yields, it is believed that 
with optimisation the Suzuki reaction could provide a suitable alternative 
method. However, in order for this to be a viable option, the synthesis of 
bromide 277 would need to be further improved. This might be achieved 
through synthesis of 277 in which the bromine substituent is already in place. 
For example, bromination of alkene 314 followed by reduction could provide us 
with a suitable substrate for methylenediazetidine synthesis (Scheme 3.55). This 
method relies on the copper-catalysed ring closure favouring four over five-
membered ring formation. Based on competition studies carried out on similar 
substrates by Li and co-workers, this might be the case and certainly merits 
further investigation.162 
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Scheme 3.55 
 
The hydrogenation of methylenediazetidine 251 has been achieved with 
excellent yield and enantioselectivity. Unfortunately, the same ligand proved to 
be unsuitable for functionalised methylenediazetidines 258, 260, 275 and 276. 
Presumably, high enantioselectivies with these substrates could be achieved, 
however a more rigorous ligand/catalyst screen would be required. If this were 
successful, the synthesis of a wide range of functionalised and enantiomerically 
enriched 1,2-diamines could be achieved, adding a new potentially powerful 
method to the literature. 
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Chapter 4: 
Experimental 
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General Information 
Anhydrous solvents were purchased in Sure/SealTM bottles from Sigma-Aldrich. 
All other solvents and reagents were used as received or purified by standard 
protocols. Petroleum ether refers to the fraction of petroleum ether having a 
boiling point between 40-60 oC. All experiments were performed under an inert 
atmosphere and moisture sensitive reactions were performed in flame-dried or 
oven-dried glassware. 
 
Column chromatography was carried out using Matrex silica 60 unless 
otherwise stated. Thin layer chromatography was performed on pre-coated 
aluminium-backed plates (Merck Kieselgel 60 F254) and were visualised using 
UV light and stained with potassium permanganate followed by heating. 
 
Melting points were recorded on a Gallenkamp MPD350 apparatus and are 
reported uncorrected. Single crystal X-ray diffraction data were obtained using 
a Siemens SMART XRD system or an Oxford Diffraction Gemini XRD system. 
Optical rotations were measured with a AA1000 polarimeter and are quoted in 
10-1 deg cm2 g-1. 
 
Infrared spectra were recorded on an Avatar 320 FT-IR or PerkinElmer 
Spectrum One FT-IR spectrometer with internal calibration. 1H and 13C spectra 
were recorded at 300 MHz and 75 MHz respectively on a Bruker DPX-300; at 
400 MHz and 100MHz respectively on a Bruker DPX-400.  Signals in the 1H 
NMR are reported as singlets (s), doublets (d), triplets (t), etc, which refer to the 
observed spin-spin coupling patterns. Chemical shifts are quoted in ppm, 
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downfield from TMS, with the residual solvent as internal standard. Coupling 
constants (J) are reported in Hertz. Ambiguous signals were assigned using 
COSY, HMQC, HMBC and nOe correlative spectra. 
 
Low-resolution mass spectra were recorded on an Esquire 2000 platform with 
electrospray ionisation. High-resolution mass spectra were obtained using a 
Bruker MicroTOF instrument. 
 
Chiral HPLC was conducted using a Gilson system using a Chiralcel AD 
column (1-5% iPrOH/n-hexane; 1.0 mL/min).  UV absorbance was monitored at 
220 nm by a Ranin Dynamax model UV-1. Racemic samples of the 
hydrogenation products were synthesised with Wilkinson’s catalyst  (Appendix 
5). 
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4-Phenyl-1,2,4-triazoline-3,5-dione (149) 
                                              
                                                    
To a stirred solution of 4-phenylurazole (200 mg, 1.13 mmol) in CH2Cl2 (20 mL) 
was added trichloromelamine (778 mg, 3.39 mmol) and the solution was stirred 
under nitrogen at room temperature for 3 h. The reaction mixture was filtered to 
separate the white precipitate and the solvent was removed in vacuo to provide 
149 (197 mg, 99%) as a red solid that was used without further purification. 1H 
NMR (300 MHz, CDCl3) 7.35 - 7.55 (5H, m, ArH), 13C NMR (75 MHz, CDCl3) 
158.7 (2C, C-3, C-5), 130.1 (1C, ArC), 129.5 (2C, ArCH), 129.1 (2C, ArCH), 
125.2 (1C, ArCH); m/z  (ES+) 176 [M+H]+. Data is in accordance with the 
reported values of Risi et al.157 
 
3-Phenyl-6-phenylsulfinyl-1,3,5-triazabicyclo[3.2.0]hepta-2,4-dione (166) 
                                                                                                
A solution of 149 (167 mg, 0.95 mmol) in CH2Cl2 (10 mL) was added to phenyl 
vinyl sulfide (0.13 mL, 0.95 mmol) in CH2Cl2 (7 mL) and stirred under nitrogen 
at room temperature for 0.5 h, by which point the solution had changed from 
deep red to pale yellow. The mixture was cooled to 0 oC and mCPBA (213 mg, 
77 %, 0.95 mmol) was added in portions over 10 minutes, the mixture was 
allowed to reach room temperature and stirred for a further 1.5 h. The mixture 
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was then washed with a NaHCO3(aq) solution  (2 x 10 mL) and brine (2 x 10 mL), 
dried over MgSO4 and concentrated in vacuo to afford a pale yellow solid. 
Column chromatography on silica gel (25% ethyl acetate in petroleum ether) 
gave 166 (22 mg, 7%) as a pale yellow solid (single diastereomer). M.p. 221.2-
221.7 oC; IR (film) 1712 (C=O), 1045 (S=O), 743 (ArH) cm-1; 1H NMR (400 
MHz, DMSO-d6) 7.48 – 7.80 (10H, m, ArH), 5.91 (1H, dd, J = 6.0, 7.3 Hz, H-6), 
4.55 (1H, dd, J = 6.0, 10.0 Hz, H-7), 4.36 (1H dd, J = 7.3, 10.0 Hz, H-7); 13C 
NMRi (100 MHz, CDCl3) 162.0 (1C, C-4) 161.1 (1C, C-2), 131.9 (ArCH), 131.4 
(1C, ArC), 129.6 (ArCH), 129.1 (ArCH), 128.8 (ArCH), 126.5 (ArCH), 124.5 
(ArCH), 79.5 (1C, C-6), 55.8 (1C, C-7); m/z (ES+) 328 [M+H]+, 350 [M+Na]+; 
HRMS (ES+) m/z calculated for C16H13N3O3SNa [M+Na]+: 350.0570; found: 
350.0578. 
 
3-Phenyl-1,3,5-triazabicyclo[3.2.0]hept-6-ene-2,4-dione (167) 
                                                  
A solution of 166 (18 mg, 0.06 mmol) in chlorobenzene (3 mL) was placed in a 
high-pressure tube that was degassed and filled with nitrogen. The tube was 
heated to 150 oC for 3 h, allowed to cool and the mixture was filtered through 
Celite. The solvent was removed in vacuo to give a viscous brown oil. Column 
chromatography (10% ethyl acetate in petroleum ether) gave 167 (5 mg, 48%) as 
a white solid. M.p. 137.8-138.4 oC; IR (film) 1728 (C=O), 1490 (Ar), 727 (Ar-
H) cm-1; 1H NMR (400 MHz, CDCl3) 7.36 – 7.47 (5H, m, ArH), 6.74 (2H, s, H-	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  i	  Aromatic	  quaternary	  carbon	  is	  not	  observed	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6, H-7); 13C NMR (100 MHz, CDCl3) 155.0 (2C, C-2, C-4), 130.9 (1C, ArCH), 
130.8 (1C, ArC), 129.5 (2C, ArCH), 129.3 (2C, ArCH), 125.4 (2C, C-6, C-7) 
m/z (ES+) 224 [M+Na]+; HRMS (ES+) m/z calculated for C10H8N3O2 [M+H]+: 
202.0611; found: 202.0610. 
 
1H-Imidazolin-2-one (185) 
                                                 
To a stirred suspension of hydantoin (4.00 g, 40.0 mmol) in THF (50 mL) at 0 oC 
was added DIBALH (1.5 M in toluene, 80 mL, 120.0 mmol) dropwise over 30 
minutes. The reaction mixture was stirred for 1 h at 0 oC. Aqueous methanol 
(90%, 200 mL) was carefully added and the mixture was stirred at reflux for 16 
h. Upon cooling the mixture was filtered and concentrated in vacuo. The crude 
product was recrystallised from ethanol to yield 185 (2.15 g, 64%) as a white 
crystalline solid. M.p. 250 - 251 oC; 1H NMR (400MHz, DMSO-d6) 9.70 (2H, br 
s, NH), 6.24 (2H, s, CH); MS (ES+) m/z 107 [M+Na]+. Data is in accordance 
with the reported values of Banti et al.112 
 
4-Phenyl-1H-imidazolin-2-one (199) 
                                                 
To a solution of 185 (1.00 g, 11.90 mmol), Pd(OAc)2 (133 mg, 0.59 mmol) and 
NaOAc.3H2O (4.85 g, 35.7 mmol) in DMSO (50 mL) was added Iodobenzene 
(2.01 mL, 17.85 mmol). The reaction mixture was stirred at 80 oC for 6 h. Upon 
NHHN
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cooling, the solvent was removed via distillation. The crude product was 
recrystallised from IPA to yield 199 as a white crystalline solid (1.12 g, 52%). 
1H NMR (400MHz, DMSO-d6) 10.50 (1H, s, NH), 10.04 (1H, s, NH), 7.49 (2H, 
d, J = 7.7 Hz, ArH) 7.31 (2H, t, J = 7.7 Hz, ArH), 7.16 (1H, t, J = 7.4 Hz, ArH) 
6.88 (1H, s, H-5); MS (ES+) m/z 183 [M+Na]+. Data is in accordance with Chen 
et al.111 
 
3-Benzylimidazolidin-2,4-dione (186) 
                                                 
To a solution of hydantoin (1.00 g, 10 mmol) and potassium carbonate (5.52 g, 
40 mmol) in DMF (25 mL) was added benzyl bromide (1.43 mL, 12 mmol) and 
stirred at 25 oC for 36 h. The reaction mixture was then diluted with water (100 
mL) and extracted with CH2Cl2 (3 x 100 mL). The combined organic layers were 
washed with water (5 x 300 mL), dried over MgSO4 and concentrated in vacuo. 
The crude product was recrystallised from ethanol to afford 186 (1.39 g, 72%) as 
a white crystalline solid. 1H NMR (400 MHz, CDCl3) 7.23 – 7.48 (5H, m, ArH), 
5.51 (1H, br s, H-1), 4.69 (2H, s, NCH2Ph) 3.98 (2H, s, H-5); (ES+) m/z = 213 
[M+Na]+. Data is in accordance with Kohn and co-workers.158 
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3-Benzyl-4-phenylimidazolin-2-one (200)   
                                             
To a solution of 186 (500 mg, 2.6 mmol) in THF (10 mL) at -25 oC was added 
phenyl magnesium chloride (15.8 mL, 1M in Et2O, 15.8 mmol). The solution 
was then allowed to warm to 25 oC. After 16 h the reaction was quenched with 
methanol (2 mL) and diluted with Et2O. The mixture was then washed with 
NH4Cl(aq) (3 x 50 mL) and concentrated in vacuo. Purification on silica gel (25% 
ethyl acetate in petroleum ether afforded 200 (188 mg, 29%)   as a white solid. 
1H NMR (400 MHz, CDCl3) 10.14 (1H, br s, H-1), 7.19 – 7.49 (8H, m, ArH) 
7.12 (2H, d, 8.0 Hz, ArH), 6.40 (1H, d, 2.5 Hz, H-5), 4.97 (2H, s, NCH2Ph); 
(ES+) m/z = 251 [M+H]+. Data is in accordance with the values reported by 
Meanwell et al.159 
 
4-Phenylimidazolidin-2-one (201) 
                                                     
A solution of 199 (300 mg, 1.88 mmol) in acetic acid (5 mL) was passed through 
an H-Cube® loaded with a 10% palladium on carbon cartridge at 100 bar, 100 oC 
until no starting material remained by LCMS. The mixture was then 
concentrated in vacuo. Purification on silica gel (50% ethyl acetate in petroleum 
ether) afforded 201 (161 mg, 53%) as a white solid. 1H NMR (400 MHz, 
DMSO-d6) 7.34 (5H, m, ArH), 6.80 (1H, s, NH), 6.26 (1H, s, NH), 4.73 (1H, dd, 
J = 6.8, 9.8 Hz, H-4), 3.69 (1H, dd, J = 9.8, 11.4 Hz, H-5), 3.01 (1H, dd, J = 6.8, 
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11.4 Hz, H-5); (ES+) m/z = 162 [M+H]+. Data is in accordance with the values 
reported by Kohn et al.158 
 
1-Phenylethane-1,2-diamine dihydrochloride (211) 
                                                 
A solution of 201 (120 mg, 0.75 mmol) in THF (3 mL) and 4M HCl (2 mL) was 
stirred at 80 oC for 6 h. Upon cooling, the reaction mixture was concentrated in 
vacuo and the resulting residue was washed with IPA to afford 211 (84 mg, 
54%) as a white solid. M.p. = 300-301 oC; 1H NMR (400 MHz, DMSO-d6) 9.01 
(6H, br s, NH), 7.60-7.70 (2H, m, ArH), 7.35-7.50 (3H, m, ArH), 4.70 (1H, t, J = 
6.5 Hz,  H-1), 3.55 (1H, dd, J = 6.5, 13.4 Hz, H-2), 3.23 (1H, dd, J = 6.5, 13.4 
Hz, H-2). Data is accordance with the values reported by Muniz and co-
workers.68   
 
Imidazolidin-2-one (203) 
                                                  
A solution of 185 (46 mg, 0.55 mmol) in methanol (5 mL) was passed through 
an H-Cube® loaded with a 10% palladium on carbon cartridge at 50 bar, 100 oC 
until no starting material remained by LCMS. The solution was then 
concentrated in vacuo. Purification on silica gel (33% ethyl acetate in petroleum 
ether) afforded 203 (29 mg, 64%) as a white solid. 1H NMR (300 MHz, DMSO-
d6) 6.11 (2H, br s, H-1, H-3) 3.26 (4H, s, H-4, H-5); (ES+) m/z = 87 [M+H]+. The 
Data is in accordance with the values reported by Mizuno et al.160 
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1,3-Diacetylimidazolin-2-one (189) 
                                                    
A solution of 185 (950 mg, 11.3 mmol) in acetic anhydride (10 mL) was stirred 
under reflux at 150 oC for 1 h. The mixture was concentrated in vacuo. 
Recrystallisation from ethanol afforded 189 (1.29 g, 68%) as a white crystalline 
solid. 1H NMR (300 MHz, DMSO-d6) 7.15 (2H, s, H-4, H-5), 2.53 (6H, s, CH3); 
(ES+) m/z = 191 [M+Na]+. Data is in accordance with the values reported by 
Banti and co-workers.112 
 
1-Acetylimidazolidin-2-one (205) 
                                                       
To a solution of 185 (75 mg, 0.45 mmol) in methanol (2 mL) was added 10% 
palladium on carbon (8 mg) and the suspension was stirred under a hydrogen 
atmosphere at 25 oC for 18 h. the reaction mixture was filtered over a plug of 
Celite®, washed through with methanol (20 ml) and concentrated in vacuo. 
Purification on silica gel (33% ethyl acetate in petroleum ether) afforded 205 (54 
mg, 95%) as a white solid. 1H NMR (300 MHz, CDCl3) 6.19 (1H, br s, H-3), 
3.96 (2H, t, J = 8.0 Hz, H-5) 3.51 (2H, t, J = 8.0 Hz, H-4), 2.50 (3H, s, CH3); 
(ES+) m/z = 151 [M+Na]+. Data is in accordance with the values reported by 
Bach and co-workers.161 
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1-Acetyl-4-phenyl-imidazolin-2-one (206) 
                                                    
To a solution of 199 (500 mg, 3.12 mmol) in DMF (10 mL) was added 
dropwise acetyl chloride (244 µL, 3.44 mmol) and triethylamine (480 µL, 3.44 
mmol) and the resulting reaction was stirred at 80 oC for 3 h. Upon cooling, the 
solution was diluted with water (50 mL) and extracted with CH2Cl2 (3 x 50 mL). 
The combined organic layers were then washed with water (5 x 150 mL), dried 
over MgSO4 and concentrated in vacuo. Purification on silica gel (25% ethyl 
acetate in petroleum ether) afforded 206 (320 mg, 46%) as a white crystalline 
solid. M.p. 236.5 – 238.1 oC; IR (film) 3151 (N-H) 1698 (C=O), 1357 (C-O), 
730 (Ar-H) cm-1; 1H NMR (400 MHz, DMSO-d6) 11.24 (1H, s, H-3) 7.46 (2H, 
d, J = 7.5 Hz, ArH), 7.30-7.46 (4H, m, ArH, H-5), 2.56 (3H, s, COCH3); 13C 
NMR (100 MHz, DMSO-d6) 167.8 (1C, C-2), 152.0 (1C, NCOCH3), 128.8 (2C, 
ArCH), 128.0 (1C, ArCH), 127.6 (1C, ArC), 124.5 (1C, C-4), 124.0 (2C, 
ArCH), 102.7 (1C, C-5), 23.6 (1C, COCH3); (ES+) m/z = 225 [M+Na]+; HRMS 
(ES+) m/z calculated for C11H10N2O2Na [M+Na]+: 225.0634; found: 225.0635. 
 
1-(2-Methylpropanoyl)-4-phenyl-imidazolin-2-one (208) 
                                                     
To a solution of 199 (500 mg, 3.12 mmol) in DMF was added 2-
methylpropanoyl chloride (360 µL, 3.44 mmol) triethylamine (480 µL, 3.44 
mmol) and the resulting reaction was stirred at 80 oC for 3 h. Upon cooling, the 
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solution was diluted with water (50 mL) and extracted with CH2Cl2 (3 x 50 mL). 
The combined organic layers were then washed with water (5 x 150 mL), dried 
over MgSO4 and concentrated in vacuo. Purification on silica gel (20% ethyl 
acetate in petroleum ether) afforded 208 (388 mg, 54%) as a white crystalline 
solid. M.p. 198.6 – 199.3 oC; IR (film) 3150 (NH), 2970 (CH), 1694 (C=O), 728 
(Ar-H); 1H NMR (400 MHz, DMSO-d6) 10.46 (1H, br s, H-3), 7.40 – 7.46 (2H, 
m, ArH) 7.19 – 7.32 (4H, m, ArH, H-5), 3.91 (1H, sept, J = 6.8 Hz, 
NCOCH(CH3)2), 1.24 (6H, d, J = 6.8 Hz, NCOCH(CH3)2); 13C NMR (100 MHz, 
DMSO-d6) 175.0 (1C, C-2), 151.5 (1C, NCOCH(CH3)2), 128.8 (2C, ArCH), 
128.1 (1C, ArCH), 128.0 (1C, ArC), 124.6 (1C, C-4), 124.1 (2C, ArCH), 103.2 
(1C, C-5), 32.3 (1C, NCOCH(CH3)2), 18.5 (2C, NCOCH(CH3)2);  (ES+) m/z = 
253 [M+Na]+; HRMS (ES+) m/z calculated for C13H14N2O2Na [M+Na]+: 
253.0947; found: 253.0947. 
 
1-(2,2-Dimethylpropanoyl)-4-phenyl-imidazol-2-one (209) 
                                                              
To a solution of 199 (500 mg, 3.12 mmol) in DMF was added 2,2-
dimethylpropanoyl chloride (424 µL, 3.44 mmol) triethylamine (480 µL, 3.44 
mmol) and the resulting reaction was stirred at 80 oC for 3 h. Upon cooling, the 
solution was diluted with water (50 mL) and extracted with CH2Cl2 (3 x 50 mL). 
The combined organic layers were then washed with water (5 x 150 mL), dried 
over MgSO4 and concentrated in vacuo. Purification on silica gel (20% ethyl 
acetate in petroleum ether) afforded 209 (388 mg, 51%) as a white crystalline 
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solid. M.p. 214.2 – 215.3 oC; IR (film) 3167 (NH), 2973 (CH3), 1715 (C=O), 
757 (Ar-H); 1H NMR (400 MHz, CDCl3) 11.11 (1H, br s, H-3) 7.48 (2H, d, J = 
7.4 Hz, ArH), 7.22 – 7.30 (4H, m, ArH, H-5), 1.46 (9H, s, 3 x CH3); 13C NMR 
(100 MHz, CDCl3) 176.8 (1C, C-2), 152.3 (1C, NCOC(CH3)3), 129.1 (2C, 
ArCH), 128.5 (1C, ArCH), 128.4 (1C, ArC), 125.2 (1C, C-4), 124.0 (2C, 
ArCH), 105.5 (1C, C-5), 41.5 (1C, NCOC(CH3)3), 25.9 (3C, NCOC(CH3)3); 
(ES+) m/z = 267 [M+Na]+; HRMS (ES+) m/z calculated for C14H16N2O2Na 
[M+Na]+: 267.1104; found: 267.1105. 
 
1-Acetyl-4-phenyl-imidazolidin-2-one (210) 
                                                        
To a solution of 206 (200 mg, 1.0 mmol) in methanol (5 mL) was added 10% 
palladium on carbon (20 mg) and the suspension was stirred under a hydrogen 
atmosphere at 25 oC for 16 h. The reaction mixture was filtered over a plug of 
Celite®, washed through with methanol (20 ml) and concentrated in vacuo. 
Purification on silica gel (25% ethyl acetate in petroleum ether) afforded 210 
(185 mg, 92%) as a crystalline white solid. M.p. 164.1 – 166.3 oC; IR (film) 
3168 (NH), 1647 (C=O), 734 (ArH); 1H NMR (400 MHz, CDCl3) 7.21 – 7.44 
(5H, m, ArH), 6.23 (1H, br s, H-3), 4.70 (1H, dd, J = 6.7, 9.8 Hz, H-4), 4.21 
(1H, dd, J = 9.7, 11.3 Hz, H-5), 3.61 (1H, dd, J = 6.5, 11.5 Hz, H-5), 2.41 (3H, 
s, CH3); 13C NMR (100 MHz, CDCl3) 170.7 (1C, C-2), 156.3 (1C, NCOCH3), 
140.5 (1C, ArC), 129.2 (2C, ArCH), 128.7 (1C, ArCH), 125.9 (2C, ArCH), 52.0 
(1C, C-4), 50.7 (1C, C-5), 23.5 (1C, CH3); (ES+) m/z = 227 [M+Na]+; HRMS 
NHN
O
Ph
Ac1
5
	    
	   135	  
(ES+) m/z calculated for C11H12N2O2Na [M+Na]+: 227.0791; found: 227.0791. 
 
N-Tosyl-5-methylene-1,3-oxazolidin-2-imine (229) 
                                                       
 To a solution of N-tosyl-N’-(2-propyn-1-yl)urea (498 mg, 1.98 mmol) in 
acetonitrile (10 mL) was added gold (III) chloride (60 mg, 0.20 mmol) and the 
mixture was heated to reflux for 2 h. Upon cooling to room temperature, 
triethylamine was added and the reaction mixture was stirred for a further 2 
minutes. The solution was then filtered over a plug of silca, washed through 
with ethyl acetate (20 mL) and concentrated in vacuo. Purification on silica gel 
(25% ethyl acetate in hexane) afforded 235 (338 mg, 68%) as a white crystalline 
solid. M.p. = 147.3 – 148.5 oC, IR (film) 3318 (N-H), 1635 (C=N), 1163 (SO2), 
851 (ArH) cm-1; 1H NMR (400 MHz, CDCl3) 8.02 (1H, br s, H-3), 7.84 (2H, d, 
J = 8.3 Hz, ArH), 7.28 (2H, d, J = 8.3 Hz, ArH), 4.87 (1H, dd, J = 2.5, 6.1 Hz, 
C=CH), 4.46 (1H, m, C=CH), 4.41 (2H, t, J = 2.5 Hz, H-4), 2.42 (3H, s, CH3); 
13C NMR (100 MHz, CDCl3) 160.0 (1C, C-2), 150.8 (1C, C-5), 143.3 (1C, 
ArC), 138.9 (1C, ArC), 129.5 (2C, ArCH), 126.4 (2C, ArCH), 88.6 (C=CH2), 
46.0 (1C, C-4), 21.5 (1C, CH3); (ES+) m/z = 275 [M+Na]+; HRMS (ES+) m/z 
calculated for C11H13N2O3S [M+H]+: 253.0641; found: 253.0639. 
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N-Tosyl-5-methyl-1,3-oxazolidin-2-imine (231), N-Tosyl-5-methyl-1,3-
oxazolin-2-imine (232) and N-tosyl-N’-propylurea (233) 
  
To a solution of 235 (200 mg, 1.0 mmol) in methanol (5 mL) was added 10% 
palladium on carbon (20 mg) and the suspension was stirred under a hydrogen 
atmosphere at 25 oC for 16 h. The reaction mixture was filtered over a plug of 
Celite®, washed through with methanol (20 ml) and concentrated in vacuo. 
Purification on silica gel (25% ethyl acetate in petroleum ether) afforded 233 
(94 mg, 19%) as a colourless oil. IR (film) 3340 (N-H), 1667 (C=N), 1156 
(SO2), 872 (ArH) cm-1; 1H NMR (400 MHz, CDCl3) 7.85 (2H, d, J = 8.5 Hz, 
ArH), 7.31 (2H, d, J = 8.5 Hz, ArH), 6.54 (1H, br m, NH), 6.26 (1H, br s, NH), 
3.15 (2H, t, J = 7.3 Hz, H-1), 2.45 (3H, s, CH3), 1.48 (2H, sex, J = 7.3 Hz, H-2), 
0.85 (3H, t, J = 7.3 Hz, H-3); 13C NMR (100 MHz, CDCl3) 152.1 (1C, CO), 
144.7 (1C, ArC), 136.7 (1C, ArC), 129.9 (1C, ArCH), 129.7 (1C, ArCH), 127.0 
(1C, ArCH), 126.4 (1C, ArCH), 42.0 (1C, C-1), 22.8 (1C, C-2), 21.5 (1C, CH3), 
11.2 (1C, CH3); (ES+) m/z = 279 [M+Na]+; HRMS (ES+) m/z calculated for 
C11H16N2O3SNa [M+Na]+: 279.0774; found: 279.0776. Further elucidation 
afforded 232 (149 mg, 30%) as a white solid. 1H NMR (400 MHz, CDCl3) 7.84 
(2H, d, J = 8.0 Hz, ArH), 7.25 (2H, d, J = 8.0 Hz, ArH), 6.53 (1H, q, J = 1.4 Hz, 
H-4), 2.40 (3H, s, CH3), 2.14 (3H, d, J = 1.4 Hz, CH3); (ES+) m/z = 275 
[M+Na]+. The data is accordance with the values reported by Padwa for isomer 
228.128 Further elucidation afforded 229 (185 mg, 26%) as a crystalline white 
solid. M.p. 138.8-139.3 oC; IR (film) 3354 (N-H) 1616 (1=N) 1153 (SO2) cm-1; 
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1H NMR (400 MHz, CDCl3) 7.78 (2H, d, J =8.2 Hz, ArH), 7.73 (1H, s, H-3), 
7.23 (2H, d, J = 8.2 Hz, ArH), 4.84 (1H, m, H-5), 3.85 (1H, t, J = 9.0 Hz, H-4), 
3.33 (1H, dd, J = 7.6, 9.1 Hz, H-4), 2.37 (3H, s, Ar-CH3), 1.40 (3H, s, -CH3); 
13C NMR (100 MHz, CDCl3) 161.5 (1C, C-2), 142.8 (1C, ArC), 139.5 (1C, 
ArC), 129.3 (2C, ArCH), 126.1 (2C, ArCH), 76.3 (1C, C-5), 49.1 (1C, C-4), 
21.5 (1C, Ar-CH3), 19.9 (1C, CHCH3); (ES+) m/z = 277 [M+Na]+; HRMS (ES+) 
m/z calculated for C11H15N2O3SNa [M+Na]+: 277.0617; found: 277.0617. 
 
Synthesis of Hydrazodicarboxylates: General Procedure 1       
 
To a mixture of alcohol (1.0 molar equiv) and triphenylphosphine (2.05 molar 
equiv) in THF at 0 °C was added drop-wise the azodicarboxylate (2.05 molar 
equiv). The reaction was allowed to reach room temperature, stirred for 24 h 
then concentrated in vacuo.  Purification of the products was achieved by 
column chromatography (petroleum ether and ethyl acetate). 
 
Diethyl 1-(2-bromoallyl)hydrazine-1,2-dicarboxylate (250) 
                                                       
250 was synthesised according to General Procedure 1 with the following: 2-
Bromoallyl alcohol (1.00 g, 7.30 mmol), triphenylphosphine (3.94 g, 14.96 
mmol), diethylazodicarboxylate (2.35 mL, 14.96 mmol) and THF (100 mL). 
Purification on silica gel (12.5% ethyl acetate in petroleum ether) afforded 250 
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(1.93 g, 90%) as a colourless oil. 1H NMR (400 MHz, CDCl3) 6.72 (1H, m, 
NH), 5.79 (1H, br s, CBr=CH), 5.57 (1H, d, J = 1.9 Hz, CBr=CH), 4.41-4.23 
(2H, m, NCH2CBr), 4.15 (4H, br q, J = 7.1 Hz, CO2CH2CH3), 1.23 (6H, t, J = 
7.1 Hz, CO2CH2CH3); MS (ES+) m/z = 319 [M(81Br)+Na]+, 317 
([M(79Br)+Na]+. Data is in accordance with the values reported by Shipman an 
co-workers.100 
 
Di-isopropyl 1-(2-bromoallyl)hydrazine-1,2-dicarboxylate (271)  
                                               
271 was synthesised according to General Procedure 1 with the following: 2-
Bromoallyl alcohol (1.56 g, 11.39 mmol), triphenylphosphine (6.16 g, 23.4 
mmol), di-isopropylazodicarboxylate (4.60 mL, 23.4 mmol) and THF (120 mL). 
Purification on silica gel (12.5% ethyl acetate in petroleum ether) afforded 271 
(2.75 g, 75%) as a white crystalline solid. M.p. 68.0 – 69.1 oC; IR (film) 3283 
(N-H) 1682 (C=O), 1628 (C=C), 761 (C-Br) cm-1; 1H NMR (400 MHz, CDCl3) 
6.50-6.86 (1H, br m, NH) 5.82 (1H, br s, CBr=CH), 5.61 (1H, s, CBr=CH), 4.97 
(2H, br m, CO2CH(CH3)2) 4.35 (2H, br s, NCH2CBr), 1.26 (12H, d, J = 6.3 Hz, 
CH3); 13C NMR (100 MHz, CDCl3) 155.8 (1C, CO2CH(CH3)2), 155.5 (1C, 
CO2CH(CH3)2), 128.2 (1C, -CBr=CH2), 119.9 and 119.4 (1C, -CBr=CH2), 70.6 
(1C, CO2CH(CH3)2), 70.0 (1C, CO2CH(CH3)2), 58.0 and 57.3 (1C, NCH2CBr), 
22.0 (2C, CH3), 21.9 (2C, CH3); MS (ES+) m/z = 345 [M(79Br)+Na]+, 347 
[M(81Br)+Na]+; HRMS (ES+) m/z calculated for C11H1979BrN2O4Na [M+Na]+: 
345.0420; found: 345.0416. 
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Di-tert-butyl 1-(2-bromoallyl)hydrazine-1,2-dicarboxylate (270) 
                                                               
270 was synthesised according to General Procedure 1 with the following: 2-
Bromoallyl alcohol (0.4 g, 2.94 mmol), triphenylphosphine (1.50 g, 6.03 mmol), 
di-tert-butyl azodicarboxylate (1.39 g, 23.4 mmol) and THF (50 mL). 
Purification on silica gel (12.5% ethyl acetate in petroleum ether) afforded 270 
(946 mg, 92%) as a white crystalline solid. M.p. 136.6 – 138.5 oC; IR (film) 
3315 (N-H), 1708 (C=O), 1146 (C-O) cm-1; 1H NMR (400MHz, CDCl3) 6.10-
6.39 (1H, br m, H-2), 5.80 (1H, br d, J = 18.2 Hz, CBr=CH), 5.59 (1H, s, 
CBr=CH), 4.30 (2H, br s, NCH2CBr), 1.47 (18H, s, C(CH3)3); 13C NMR (100 
MHz, CDCl3) 154.7 (2C, CO2C(CH3)3), 128.8 (1C, -CBr=CH2), 119.4 (1C, -
CBr=CH2), 81.8 (2C, CO2C(CH3)3), 58.3 (1C, NCH2CBr), 28.2 (3C, -C(CH3)3), 
28.1 (3C, -C(CH3)3); MS (ES+) m/z = 373 [M(79Br)+Na]+, 375 [M(81Br)+Na]+; 
HRMS (ES+) m/z calculated for C13H2379BrN2O4Na [M+Na]+: 373.0733; found: 
373.0731. 
  
Di-ethyl 1-(2-bromo-3-methylbut-2-enyl)hydrazine-1,2-dicarboxylate (272) 
                                                        
272 was synthesised according to General Procedure 1 with the following: 2-
bromo-3-methylbut-2-en-1-ol (1.00 g, 6.06 mmol), triphenylphosphine (3.24 g, 
12.42 mmol), diethylazodicarboxylate (2.65 mL, 12.42 mmol) and THF (100 
mL). Purification on silica gel afforded 272 (1.42 g, 75%) as a colourless oil. IR 
(film) 3300 (N-H), 2985 (C-H), 1704 (C=O), 730 (C-Br); 1H NMR (400 MHz, 
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CDCl3) 6.31-6.58 (1H, m, NH), 4.51 (2H, br s, NCH2CBr), 4.23 (4H, q, J = 7.1 
Hz, CO2CH2CH3), 1.91 (3H, s, CH3), 1.83 (3H, s, CH3), 1.27, (6H, t, J = 7.1 Hz, 
CO2CH2CH3); 13CNMR (100 MHz, CDCl3) 156.0 (1C, CO2C(CH3)3), 155.4 (1C, 
CO2C(CH3)3), 137.0 and 136.6 (1C, -CBr=C(CH3)2), 115.3 (1C, -CBr=C(CH3)2), 
62.5 (1C, CO2CH2CH3), 61.9 (1C, CO2CH2CH3), 53.9 and 53.3 (1C, NCH2CBr), 
25.5 (1C, CH3), 20.4 (1C, CH3), 14.4 (1C, CH3), 14.1(1C, CH3); MS (ES+) m/z = 
345 [M(79Br)+Na]+, 347 [M(81Br)+Na]+; HRMS (ES+) m/z calculated for 
C11H1979BrN2O4Na [M+Na]+: 345.0420; found: 345.0225. 
 
Synthesis of 3-methylene-1,2-diazetidines: General Procedure 2 
               
To a mixture of hydrazodicarboxylate (1.0 molar equiv.), CuI (0.2 molar equiv) 
and Cs2CO3 (2.0 molar equiv.) in THF was added dropwise N,N'-
dimethylethylenediamine  (DMEDA) (0.4 molar equiv) and the mixture stirred 
at reflux for 16 h. The reaction was allowed to cool to room temperature, 
filtered through a plug of silica and concentrated in vacuo. The crude product 
was purified by column chromatography (petroleum ether:ethyl acetate). 
 
Diethyl 3-methylene-1,2-diazetidine-1,2-dicarboxylate (251) 
                                               
251 was synthesised according to General Procedure 2 with the following: 250 
(1.87 g, 6.37 mmol), copper iodide (242 mg, 1.26 mmol), DMEDA (275 µL, 
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2.55 mmol), Cs2CO3 (4.16 g, 12.75 mmol) and THF (50 mL). Purification on 
silica gel (20% ethyl acetate in petroleum ether) afforded 251 (1.31 g, 96%) as a 
colourless oil. 1H NMR (400 MHz, CDCl3) 4.94 (1H, dt, J = 3.3, 2.3 Hz, 
C=CH), 4.65 (2H, t, J = 2.3 Hz, H-4), 4.40 (1H, dt, J = 3.3, 2.3 Hz, C=CH), 
4.28 (2H, q, J = 7.1 Hz, CO2CH2CH3), 4.22 (2H, q, J = 7.1 Hz, CO2CH2CH3), 
1.31 (3H, t, J = 7.1 Hz, CO2CH2CH3), 1.28 (3H, t, J = 7.1 Hz, CO2CH2CH3); 
MS (ES+) m/z = 237 [M+Na]+. Data is in accordance with the values reported 
by Shipman and co-workers.100 
 
Di-iso-propyl 3-methylene-1,2-diazetidine-1,2-dicarboxylate (273) 
                                           
273 was synthesised according to General Procedure 2 with the following: 271 
(821 mg, 2.55 mmol), copper iodide (97 mg, 0.51 mmol), DMEDA (108 µL, 
1.02 mmol), Cs2CO3 (1.66 g, 5.10 mmol) and THF (20 mL). Purification on 
silica gel (20% ethyl acetate in petroleum ether) afforded 273 (567 mg, 92%) as 
a colourless oil. IR (film) 2982 (>CH3), 1716 (C=O), 1091 (C-O) cm -1; 1H 
NMR (400 MHz, CDCl3) 4.96 – 5.10 (3H, m, C=CH, 2 x COCH(CH3)2), 4.63–
4.65 (2H, m, H-4), 4.39–4.41 (1H, m, C=CH), 1.33 (6H, d, J = 6.2 Hz, 
CH(CH3)2) , 1.29 (6H, d, J = 6.2 Hz, CH(CH3)2); 13CNMR (100 MHz, CDCl3) 
160.1 (1C, CO2CH(CH3)2), 154.9 (1C, CO2CH(CH3)2) 142.4 (1C, C-3),  90.1 
(1C, C=CH2) 71.0 (1C, COCH(CH3)2) 70.1 (1C, COCH(CH3)2)  56.2 (1C, C-4), 
21.9 (1C, CH3), 21.8 (1C, CH3), 21.7 (1C, CH3), 21.5 (1C, CH3); MS (ES+) m/z 
= 265 [M+Na]+, HRMS (ES+) m/z calculated for C11H19N2O4Na [M+Na]+: 
265.1159; found: 265.1156.   
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Di-tert-butyl 3-methylene-1,2-diazetidine-1,2-dicarboxylate (252) 
                                            
252 was synthesised according to General Procedure 2 with the following: 270 
(534 mg, 1.52 mmol), copper iodide (58 mg, 0.31 mmol), DMEDA (67 µL, 0.62 
mmol), Cs2CO3 (985 mg, 3.02 mmol) and THF (10 mL). Purification on silica 
gel (20% ethyl acetate in petroleum ether) afforded 252 (398 mg, 97%) as a 
colourless oil. 1H NMR (400 MHz, CDCl3) 4.91-4.87 (1H, m, C=CH), 4.59 (2H, 
t, J = 2.3 Hz, H-4), 4.37-4.34 (1H, m, C=CH), 1.54 (9H, s, C(CH3)3), 1.50 (9H, 
s, C(CH3)3); MS (ES+) m/z = 293 [M+Na]+. Data is in accordance with the 
values reported by Shipman and co-workers.100 
 
Diethyl 3-(propan-2-ylidene)-1,2-diazetidine-1,2-dicarboxylate (274) 
                                            
274 was synthesised according to General Procedure 2 with the following: 272 
(870 mg, 2.70 mmol), copper iodide (118 mg, 0.62 mmol), DMEDA (132 µL, 
1.24 mmol), Cs2CO3 (2.03 g, 6.22 mmol) and THF (20 mL). Purification on 
silica gel (20% ethyl acetate in petroleum ether) afforded 274 (610 mg, 93%) as 
a colourless oil. IR (film) 2985 (-CH3), 1710 (C=O), 1269 (C-O) cm-1; 1H NMR 
(400 MHz, CDCl3) 4.68 (2H, br s, H-4), 4.23 (2H, 2H, J = 7.1 Hz, 
CO2CH2CH3), 4.23 (2H, 2H, J = 7.1 Hz, CO2CH2CH3), 1.78 (3H, m, 
C=C(CH3)2), 1.49 (3H, br s, C=C(CH3)2), 1.29 (3H, t, J = 7.1 Hz, CO2CH2CH3), 
1.27 (3H, t, J = 7.1 Hz, CO2CH2CH3); 13C NMR (100 MHz, CDCl3) 160.5 (1C, 
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CO2CH2CH3), 157.8 (1C, CO2CH2CH3), 129.3 (1C, C-3), 113.5 (1C, 
C=C(CH3)2), 62.9 (1C, CO2CH2CH3), 62.8 (1C, CO2CH2CH3), 58.4 (1C, C-4), 
18.6 (1C, C=C(CH3)2), 18.4 (1C, C=C(CH3)2), 14.4 (1C, CO2CH2CH3), 14.3 
(1C, CO2CH2CH3); MS (ES+) m/z = 265 [M+Na]+, HRMS (ES+) m/z calculated 
for C11H19N2O4Na [M+Na]+: 265.1159; found: 265.1155. 
  
General Procedure 3 
              
To a stirred mixture of diethyl 3-methylene-1,2-diazetidine-1,2-dicarboxylate (1 
molar equiv.), phenyl iodide (1.5 molar equiv.), Bu4NCl (1 molar equiv) and 
Pd(OAc)2 (0.04 molar equiv.), in dimethylacetamide was added Cy2NMe (1.5 
molar equiv.). The reaction was stirred at 70 °C until no starting material 
remained by tlc, allowed to cool to room temperature and diluted with Et2O and 
water. The phases were separated and the aqueous layer extracted with Et2O. 
The combined extracts were washed with water, dried over MgSO4, filtered, and 
concentrated in vacuo. The crude product was purified on silica gel (ethyl 
acetate in hexane). 
 
Diethyl (3E)-3-benzylidene-1,2-diazetidine-1,2-dicarboxylate (258) 
                                               
258 was synthesised according to General Procedure 3 with the following: 251 
(500 mg, 2.34 mmol), phenyl iodide (0.391 mL, 3.51 mmol), Bu4NCl (651 mg, 
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2.34 mmol), palladium (II) acetate (21 mg, 0.09 mmol), Cy2NMe (0.74 mL, 
3.51 mmol) and DMAc (10 mL). Purification on silica gel (12.5% ethyl acetate 
in hexane) afforded 258 (304 mg, 45%) as a white crystalline solid. 1H NMR 
(400 MHz, CDCl3) 7.31 (2H, t, J = 7.5 Hz, ArH), 7.18 (1H, t, J = 7.5 Hz, ArH), 
7.03 (2H, d, J = 7.5 Hz, ArH), 6.49 (1H, d, J = 2.5 Hz C=CHPh), 5.00 (2H, d, J 
= 2.5 Hz, H-4), 4.35 (2H, q, J = 7.1 Hz, CO2CH2CH3), 4.29 (2H, q, J = 7.2 Hz, 
CO2CH2CH3), 1.38 (3H, t, J = 7.2 Hz, CO2CH2CH3), 1.33 (3H, t, J = 7.1 Hz, 
CO2CH2CH3); MS (ES+) m/z = 313 [M+Na]+. Data is in accordance with that 
reported by Shipman and co-workers.100 
 
Diethyl (3E)-3-benzylidene-1,2-diazetidine-1,2-dicarboxylate (258) with 
Suzuki coupling 
                  
To a stirred solution of 277 (40 mg, 0.14 mmol) in 1,4-dioxane (1 mL) was 
added PhB(OH)2 (50 mg, 0.41 mmol), XPhos (4 mg, 0.008 mmol), Pd2dba3 (3 
mg, 0.003 mmol) and Cs2CO3 (98 mg, 0.30 mmol). The reaction was stirred at 
110 oC for 1 h. Upon cooling, the reaction mixture was filtered over Celite®, 
washed through with CH2Cl2 (10 mL) and concentrated in vacuo. Purification 
on silica gel (12.5% ethyl acetate in hexane) afforded 258 (19 mg, 50%) as a 
white crystalline solid. Data is as previously described. 
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Diethyl (3E)-3-(4-tert-butyl-benzylidene)-1,2-diazetidine-1,2-dicarboxylate 
(276) 
                                                
276 was synthesised according to General Procedure 3 with the following: 251 
(200 mg, 0.94 mmol), 4-tert-butyliodobenzene (0.198 mL, 1.12 mmol), Bu4NCl 
(260 mg, 0.94 mmol), palladium (II) acetate (15 mg, 0.07 mmol), Cy2NMe (238 
mg, 1.12 mmol) and DMAc (6 mL). Purification on silica gel (12.5% ethyl 
acetate in hexane) afforded 276 (136 mg, 42%) as a colourless oil. IR (neat) 
2963 (CH3), 1720 (C=O), 1316 (C-O) cm-1; 1H NMR (400 MHz, CDCl3) 7.34 
(2H, d, J = 8.4 Hz, ArH), 6.98 (2H, d, J = 8.4 Hz, ArH), 6.44 (1H, t, J = 2.4 Hz, 
C=CHAr), 5.01 (2H, d, J = 2.4 Hz, H-4), 4.36 (2H, q, J = 7.1 Hz, CO2CH2CH3), 
4.29 (2H, q, J = 7.1 Hz, CO2CH2CH3), 1.38 (3H, t, J = 7.1 Hz, CO2CH2CH3) 
1.34 (3H, t, J = 7.1 Hz, CO2CH2CH3), 1.31 (9H, s, Ar-C(CH3)3); 13C NMR (100 
MHz, CDCl3) 160.5 (CO2CH2CH3),  155.5 (CO2CH2CH3), 149.6 (1C, ArC), 
136.5 (1C, C-3), 131.8 (1C, ArC), 126.4 (2C, ArCH), 125.8 (2C, ArCH), 63.3 
(1C, CO2CH2CH3),  63.1 (1C, CO2CH2CH3),   58.5 (1C, C-4),   34.5 (1C, Ar-
C(CH3)3),   31.3 (3C, Ar-C(CH3)3), 14.5 (1C, CO2CH2CH3), 14.4 (1C, 
CO2CH2CH3); MS (ES+) m/z = 369 [M+Na]+, HRMS (ES+) m/z calculated for 
C19H26N2O4Na [M+Na]+: 369.1785; found: 365.1786. 
 
 
 
 
NN
CO2EtEtO2C
4
1
C6H4tBu
	    
	   146	  
Diethyl (3E)-3-(4-methoxybenzylidene)-1,2-diazetidine-1,2-dicarboxylate 
(260) 
                                             
260 was synthesised according to General Procedure 3 with the following: 251 
(200 mg, 0.94 mmol), 4-iodoanisole (528 mg, 1.40 mmol), Bu4NCl (260 mg, 
0.94 mmol), palladium (II) acetate (15 mg, 0.07 mmol), Cy2NMe (0.30 mL, 1.4 
mmol) and DMAc (6 mL). Purification on silica gel (12.5% ethyl acetate in 
hexane) afforded 260 (101 mg, 34%) as a colourless oil. 1H NMR (400 MHz, 
CDCl3) 6.94 (2H, d, J = 8.9 Hz, ArH), 6.83 (2H, d, J = 8.9 Hz, ArH), 6.38 (1H, 
t, J = 2.5 Hz, C=CHAr), 4.96 (2H, d, J = 2.5 Hz, H-4), 4.32 (2H, q, J = 7.1 Hz, 
CO2CH2CH3), 4.26 (2H, q, J = 7.1 Hz, CO2CH2CH3), 3.77 (3H, s, OCH3), 1.34 
(3H, t, J = 7.1 Hz, CO2CH2CH3), 1.30 (3H, t, J = 7.1 Hz, CO2CH2CH3); MS 
(ES+) m/z = 343 [M+Na]+. The data is in accordance with that reported by 
Shipman and co-workers.100 
 
Diethyl (3E)-3-(naphthalene-2-ylidene)-1,2-diazetidine-1,2-dicarboxylate 
(275) 
                                             
275 was synthesised according to General Procedure 3 with the following: 251 
(200 mg, 0.94 mmol), 2-iodonaphthalene (285 mg, 1.12 mmol), Bu4NCl (260 
mg, 0.94 mmol), palladium (II) acetate (15 mg, 0.07 mmol), Cy2NMe (238 mg, 
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1.12 mmol) and DMAc (6 mL). Purification on silica gel (10% ethyl acetate in 
hexane) afforded 275 (101 mg, 34%) as a white crystalline solid. M.p 113.2 – 
113.8 oC; IR (neat) 2981 (-CH3), 1713 (C=O), 1284 (C-O), 745 (Ar-H) cm-1; 1H 
NMR (400 MHz, CDCl3) 7.74-7.80 (3H, m, ArH), 7.40-7.49 (3H, m, ArH), 7.13 
(1H, dd, J = 1.7 and 8.6 Hz, ArH), 6.63 (1H, t, J = 2.4 Hz, C=CHAr), 5.11 (2H, 
d, J = 2.4 Hz, H-4), 4.38 (2H, q, J = 7.1 Hz, CO2CH2CH3), 4.34 (2H, q, J = 7.1 
Hz, CO2CH2CH3), 1.41 (3 H, t, J = 7.1 Hz, CO2CH2CH3), 1.35 (3H, t, J = 7.1 
Hz, CO2CH2CH3); 13C NMR (100 MHz, CDCl3) 160.4 (1C, CO2CH2CH3), 155.4 
(1C, CO2CH2CH3), 137.5 (1C, C-3), 133.7 (1C, ArC) 132.2 (1C, ArC), 132.0 
(1C, ArC), 128.5 (1C, ArCH), 127.7 (1C, ArCH), 127.6 (1C, ArCH), 126.5 (1C, 
ArCH), 125.9 (1C, ArCH), 125.7 (1C, ArCH), 124.4 (1C, ArCH), 108.2 (1C, 
C=CHAr) 63.3 (1C, CO2CH2CH3), 63.2 (1C, CO2CH2CH3), 58.6 (1C, C-4), 14.5 
(1C, CO2CH2CH3), 14.4 (1C, CO2CH2CH3); MS (ES+) m/z = 363 [M+Na]+, 
HRMS (ES+) m/z calculated for C19H21N2O4 [M+H]+: 341.1496; found: 
341.1497. 
  
 
Diethyl (3E)-3-(bromomethylene)-1,2-diazetidine-1,2-dicarboxylate (277) 
                                            
To a stirred solution of 251 (200 mg, 0.94 mmol) in CH2Cl2 (4 mL) at -78 oC 
was added bromine (0.046 mL) dropwise. After 1 h the solution was allowed to 
reach -60 oC, DBU was added dropwise and the reaction mixture was stirred for 
a further 4 h whilst being allowed to slowly warm to 25 oC.  The reaction 
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mixture was poured into brine (20 mL) and extracted with CH2Cl2 (3 x 20 ml). 
The combined organic layers were dried over MgSO4, filtered and concentrated 
under vacuum. Purification on silica gel (10% ethyl acetate in petroleum ether) 
afforded 277 (115 mg, 42%) as a colourless oil. IR (film) 2983 (CH3), 1731 
(C=O), 694 (C-Br) cm-1; 1H NMR (400 MHz, CDCl3) 6.05 (1H, t, J = 2.6 Hz, 
C=CHBr), 4.62 (2H, d, J = 2.6 Hz, H-4), 4.32 (2H, q, J = 7.1 Hz, CO2CH2CH3), 
4.27 (2H, q, J = 7.1 Hz, CO2CH2CH3), 1.35 (3H, t, J = 7.1 Hz, CO2CH2CH3), 
1.32 (3H, t, J = 7.1 Hz, CO2CH2CH3); 13C NMR (150 MHz, CDCl3) 159.2 (1C, 
CO2CH2CH3), 153.7 (1C, CO2CH2CH3), 137.8 (1C, C-3), 84.1 (1C, C=CHBr), 
62.5 (1C, CO2CH2CH3), 62.4 (1C, CO2CH2CH3), 57.0 (1C, C-4), 13.3 (1C, 
CO2CH2CH3), 13.3 (1C, CO2CH2CH3); MS (ES+) m/z = 315 [M(79Br)+Na]+, 317 
[M(81Br)+Na]+, HRMS (ES+) m/z calculated for C9H1379BrN2O4Na 
[M(79Br)+Na]+: 314.9951; found: 314.9952. 
 
Diethyl 3-methyl-1,2-diazetidine-1,2-dicarboxylate (280) and diethyl 1-
(propyl)hydrazine-1,2-dicarboxylate (281) 
 
To a solution of 251 (200 mg, 0.93 mmol) in methanol (5 mL) was added 10% 
palladium on carbon (20 mg) and the suspension was stirred under a hydrogen 
atmosphere at 25 oC for 16 h. The reaction mixture was filtered over a plug of 
Celite®, washed through with methanol (20 ml) and concentrated in vacuo. 
Purification on silica gel (12.5% ethyl acetate in petroleum ether) afforded 281 
(47 mg, 23%) as a colourless oil. IR (film) 3295 (N-H), 2983 (C-H), 1694 
(C=O) cm-1; 1H NMR (400 MHz, CDCl3) 6.31-6.64 (1H, m, H-2), 4.14-4.22 
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(4H, m, CO2CH2CH3), 3.46 (2H, m, NCH2CH2CH3), 1.59 (2H, quin, J = 7.3 Hz, 
NCH2CH2CH3), 1.24-1.28 (6H, m, CO2CH2CH3), 0.90 (3H, t, J = 7.3 Hz, 
NCH2CH2CH3); 13C NMR (100 MHz, CDCl3) 156.3 (2C, CO2CH2CH3), 62.4 
(1C, CO2CH2CH3), 62.0 (1C, CO2CH2CH3), 42.7 (1C, NCH2CH2CH3) 20.7 (1C, 
NCH2CH2CH3), 14.6 (1C, CO2CH2CH3), 14.5 (1C, CO2CH2CH3), 11.1 (1C, 
NCH2CH2CH3); MS (ES+) m/z = 241 [M+Na]+, HRMS (ES+) m/z calculated for 
C9H18N2O4Na [M+Na]+: 241.1159; found: 241.1160. Further elucidation 
afforded 280 (108 mg, 54%) as a colourless oil. IR (film) 2977 (CH3), 1702 
(C=O), 1273 (C-O) cm-1; 1H NMR (400 MHz, CDCl3) 4.39-4.47 (1H, m, H-3), 
4.32 (1H, t, J = 8.0 Hz, H-4), 4.15-4.27 (4H, m, CO2CH2CH3), 3.74 (1H, dd, J = 
6.2, 8.0 Hz, H-4), 1.48 (3H, d, J = 6.3 Hz, >CHCH3), 1.28 (6H, t, J = 7.2 Hz, 
CO2CH2CH3); 13C NMR (100 MHz, CDCl3) 161.1 (1C, CO2CH2CH3), 160.9 
(1C, CO2CH2CH3), 62.6 (1C, CO2CH2CH3), 62.4 (1C, CO2CH2CH3), 58.1 (1C, 
C-3), 56.1 (1C, C-4), 20.7 (1C, >CHCH3), 14.4 (2C, CO2CH2CH3); MS (ES+) 
m/z = 239 [M+Na]+, HRMS (ES+) m/z calculated for C9H16N2O4Na [M+Na]+: 
239.1002; found: 239.1004.   
                  
  General Procedure 4 
                   
To a test tube containing a solution of 3-methylene-1,2-diazetidine-1,2-
dicarboxylate (1 molar equiv.) in ethyl acetate was added the rhodium catalyst 
(0.011 molar equiv.) followed by the ferrocene-based ligand (0.014 molar 
equiv). The test tube was placed within a high pressure Parr hydrogenator, 
N N
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purged with hydrogen three times and then charged with hydrogen to 50 Bar. 
The reaction was stirred at 50 oC for the required amount of time, allowed to 
cool and concentrated in vacuo. Purification on silica gel (ethyl acetate in 
hexane) afforded the desired compound.   
 
 (S)-Diethyl 3-methyl-1,2-diazetidine-1,2-dicarboxylate ((S)-280) 
                                            
280 was synthesised according to General Procedure 4 with the following: 251 
(250 mg, 1.17 mmol), [Rh(NBD)2].BF4 (5 mg, 0.01 mmol), (SP,S′P)-1,1′-Bis 
[bis(4-methoxy-3,5-dimethylphenyl) phosphino]- 2,2′- bis [ (R) - α-
(dimethylamino)benzyl]ferrocene (17 mg, 0.02 mmol) and ethyl acetate (2 mL). 
Purification on silica gel (15 % ethyl acetate in hexane) afforded 280 (244 mg, 
98%, 89% ee) as a colourless oil. Spectroscopic data as previously described. 
 
Diethyl 3-methyl-1,2-diazetidine-1,2-dicarboxylate (284) 
                                           
284 was synthesised according to General Procedure 4 with the following: 252 
(50 mg, 0.19 mmol), [Rh(NBD)2]BF4 (1 mg, 0.01 mmol), (SP,S′P)-1,1′-Bis 
[bis(4-methoxy-3,5-dimethylphenyl) phosphino]- 2,2′- bis [ (R) - α-
(dimethylamino)benzyl]ferrocene (3 mg, 0.001 mmol) and ethyl acetate (2 ml). 
Purification on silica gel (12.5% ethyl acetate in hexane) afforded 284 (26 mg, 
52%, 52% ee) as a colourless oil. [α]30D = +24.5 (EtOAc);  IR (neat) 2979 
(CH3), 1700 (C=O), 1158 (C-O) cm-1; 1H NMR (400 MHz, CDCl3) 4.29-4.36 
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(1H, m, H-3), 4.21 (1H, t, J = 7.9 Hz, H-4), 3.65 (1H, dd, J = 6.4, 7.9 Hz), 1.49 
(9H, s, CO2C(CH3)3), 1.48 (9H, s, CO2C(CH3)3), 1.45 (3H, d, J = 6.4 Hz, >C-
CH3); 13C NMR (100 MHz, CDCl3) 160.1 (1C, CO2C(CH3)3), 160.0 (1C, 
CO2C(CH3)3), 81.8 (1C, CO2C(CH3)3), 81.7 (1C, CO2C(CH3)3), 57.4 (1C, C-3), 
55.6 (1C, C-4), 28.1 (6C, CO2C(CH3)3), 20.7 (1C, >C-CH3); MS (ES+) m/z = 
295 [M+Na]+, HRMS (ES+) m/z calculated for C13H24N2O4Na [M+Na]+: 
295.1652; found: 295.1652. 
 
Diethyl 3-benzyl-1,2-diazetidine-1,2-dicarboxylate (282) 
                                              
282 was synthesised according to General Procedure 4 with the following: 258 
(50 mg, 0.17 mmol), [Rh(NBD)2]BF4 (1 mg, 0.01 mmol), (R)-1-[(SP)-2-
(diphenylphosphino)ferrocenyl]ethyldicyclohexylphosphine (2 mg, 0.01 mmol), 
and ethyl acetate (2 mL). Purification of silica gel (20% ethyl acetate in hexane) 
afforded 282 (27 mg, 54% 33% ee) as a colourless oil. [α]30D = +36.0 (EtOAc); 
IR (film) 2984 (CH3), 1705 (C=O), 1270 (C-O), 702 (Ar-H) cm-1; 1H NMR (400 
MHz, CDCl3) 7.18-7.30 (5H, m, ArH), 4.52-4.59 (1H, m, H-3), 4.06-4.26 (5H, 
m, H-4, 2 x CO2CH2CH3), 3.82 (1H, dd, J = 6.0, 8.4 Hz, H-4), 3.11 (1H, dd, J = 
5.0, 14.0 Hz, -CHPh), 3.04 (1H, dd, J = 7.7, 14.0 Hz, -CHPh), 1.25 (3H, t, J = 
7.1 Hz, CO2CH2CH3), 1.22 (3H, t, J = 7.1 Hz, CO2CH2CH3); 13C NMR (100 
MHz, CDCl3) 160.8 (2C, CO2CH2CH3), 135.4 (1C, ArC), 129.5 (2C, ArCH), 
128.4 (2C, ArCH), 126.4 (1C, ArCH), 62.5 (2C, CO2CH2CH3), 62.1 (1C, C-3), 
53.8 (1C, C-4), 40.2 (1C,  -CH2Ph), 14.4 (2C, CO2CH2CH3); MS (ES+) m/z = 
1NN
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315 [M+Na]+, HRMS (ES+) m/z calculated for C15H20N2O4Na [M+Na]+: 
315.1315; found: 315.1311. 
 
Diethyl 3-(4-methoxybenzyl)-1,2-diazetidine-1,2-dicarboxylate (287) 
                                              
287 was synthesised according to General Procedure 4 with the following: 260 
(50 mg, 0.16 mmol), [Rh(NBD)2]BF4 (1 mg, 0.01 mmol), (R)-1-[(SP)-2-
(diphenylphosphino)ferrocenyl]ethyldicyclohexylphosphine (2 mg, 0.01 mmol), 
and ethyl acetate (2 mL). Purification on silica gel (20% ethyl acetate in hexane) 
afforded 287 (17 mg, 34%, 18% ee) as a colourless oil. [α]30D = +12.3 (EtOAc);  
IR (neat) 2980 (CH3), 1705 (C=O), 1244 (C-O), 769 (ArH) cm-1; 1H NMR (400 
MHz, CDCl3), 7.13 (2H, d, J = 8.6 Hz, ArH), 6.84 (2H, d, J = 8.6 Hz, ArH), 
4.50-4.57 (1H, m, H-3), 4.07-4.30 (5H, m, H-4, 2 x CO2CH2CH3), 3.83 (1H, dd, 
J = 6.1, 8.4 Hz, H-4), 3.79 (3H, s, -OCH3), 3.07 (1H, dd, J = 4.9, 14.1 Hz, -
CHAr), 3.00 (1H, dd, J = 7.6, 14.1 Hz, -CHAr), 1.28 (3H, t, J = 7.2 Hz, 
CO2CH2CH3), 1.24 (3H, t, J = 7.2 Hz, CO2CH2CH3); 13C NMR (150 MHz, 
CDCl3) 160.8 (2C, CO2CH2CH3), 158.7 (1C, ArC-OCH3), 130.5 (2C, ArCH), 
127.3 (1C, ArC), 114.0 (2C, ArCH), 62.5 (2C, CO2CH2CH3), 62.3 (1C, C-3), 
55.2 (Ar-OCH3), 53.7 (1C, C-4), 39.2 (1C, -CH2Ar), 14.4 (2C, CO2CH2CH3); 
MS (ES+) m/z = 345 [M+Na]+, HRMS (ES+) m/z calculated for C16H22N2O5Na 
[M+Na]+: 345.1421; found: 345.1419. 
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Diethyl 3-(4-tert-butlylbenzyl)-1,2-diazetidine-1,2-dicarboxylate (285) 
                                              
285 was synthesised according to General Procedure 4 with the following: 276 
(80 mg, 0.23 mmol), [Rh(NBD)2]BF4 (1 mg, 0.01 mmol), (R)-1-[(SP)-2-
(diphenylphosphino)ferrocenyl]ethyldicyclohexylphosphine (3 mg, 0.01 mmol), 
and ethyl acetate (2 mL). Purification on silica gel (10% ethyl acetate in hexane) 
afforded 285 (46 mg, 58%, 19% ee) as a colourless oil. [α]30D = +14.6 (EtOAc);   
IR (film) 2959 (CH3), 1707 (C=O), 1270 (C-O) cm-1; 1H NMR (400 MHz, 
CDCl3) 7.32 (2H, d, J = 8.5 Hz, ArH), 7.14 (2H, d, J = 8.5 Hz, ArH), 4.53-4.59 
(1H, m, H-3), 4.07-4.29 (5H, H-4, 2 x CO2CH2CH3), 3.85 (1H, dd, J = 6.0, 8.3 
Hz, H-4), 3.11 (1H, dd, J = 4.8, 14.1 Hz, -CHAr), 3.03 (1H, dd, J = 8.0, 14.1 
Hz, -CHAr), 1.30 (9H, s, -C(CH3)3), 1.27 (3H, t, J = 7.1 Hz, CO2CH2CH3), 1.24 
(3H, t, J = 7.1 Hz, CO2CH2CH3); 13C NMR (100 MHz, CDCl3) 160.9 (2C, 
CO2CH2CH3), 149.9 (1C, ArC-C(CH3)3), 132.3 (1C, ArC), 129.2 (2C, ArCH), 
125.5 (2C, ArCH), 62.5 (2C, CO2CH2CH3), 62.2 (1C, C-3), 53.9 (1C, C-4), 39.7 
1C, -CH2Ar), 34.5 (1C, Ar-C(CH3)3), 31.4 (3C, Ar-C(CH3)3), 14.4 (2C, 
CO2CH2CH3); MS (ES+) m/z = 371 [M+Na]+, HRMS (ES+) m/z calculated for 
C19H28N2O4Na [M+Na]+: 371.1941; found: 371.1933. 
 
 
 
 
 
1NN
CO2EtEtO2C
4
C6H4tBu
	    
	   154	  
Diethyl 3-(naphthalene-2-ylmethyl)-1,2-diazetidine-1,2-dicarboxylate (286) 
                                             
286 was synthesised according to General Procedure 4 with the following: 275 
(40 mg, 0.118 mmol), [Rh(NBD)2]BF4 (1 mg, 0.003 mmol), (R)-1-[(SP)-2-
(diphenylphosphino)ferrocenyl]ethyldicyclohexylphosphine (3 mg, 0.003 
mmol), and ethyl acetate (2 mL). Purification on silica gel (12.5% ethyl acetate 
in hexane) afforded 286 (22 mg, 55%, <30% ee) as a colourless oil. [α]30D = 
+22.1 (EtOAc);    IR (film) 2981 (CH3), 1749 (C=O), 1296 (C-O), 750 (ArH) 
cm-1; 1H NMR (400 MHz, CDCl3), 7.78-7.82 (3H, m, ArH), 7.67 (1H, s, ArH), 
7.43-7.49 (2H, m, ArH), 7.35 (1H, dd, J = 1.7, 8.4 Hz, ArH), 4.64-4.70 (1H, m, 
H-3), 3.96-4.30 (5H, m , H-4, 2 x CO2CH2CH3), 3.90 (1H, dd, J = 6.0, 8.4 Hz, 
H-4), 3.30 (1H, dd, J = 4.9, 14.0 Hz, -CHAr), 3.23 (1H, dd, J = 7.6, 14.0 Hz, 
CHAr), 1.24 (3H, t, J = 7.1 Hz, CO2CH2CH3), 1.15 (3H, t, J = 7.1 Hz, 
CO2CH2CH3); 13C NMR (100 MHz,CDCl3) 160.9 (1C, CO2CH2CH3), 160.8 (1C, 
CO2CH2CH3), 133.5 (1C, ArC), 132.9 (1C, ArC), 132.5 (1C, ArC), 128.2 (1C, 
ArCH), 128,1 (1C, ArCH), 127.7 (1C, ArCH), 127.6 (1C, ArC), 127.5 (1C, 
ArCH), 126.2 (1C, ArCH), 125.8 (1C, ArCH), 62.6 (1C, CO2CH2CH3), 62.5 
(1C, CO2CH2CH3), 62.2 (1C, C-3), 53.9 (1C, C-4), 40.4 (1C, -CH2Ar), 14.4 (1C, 
CO2CH2CH3),  14.3 (1C, CO2CH2CH3); MS (ES+) m/z = 365 [M+Na]+, HRMS 
(ES+) m/z calculated for C19H22N2O4Na [M+Na]+: 365.1472; found: 365.1472. 
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General Procedure 5 
               
A stock solution of LiDBB in THF was prepared as follows: Freshly cut pellets 
of lithium (66 mg, 9.40 mmol) were placed in a flask containing 4,4'-di-tert-
butylbiphenyl (500 mg, 1.88 mmol). The tube was evacuated and filled with 
argon 3 times. THF (5 mL) was added and stirring continued for 15 minutes 
whereupon the solution turned dark green. The vessel was cooled to -78 °C 
under an argon atmosphere and used directly. To a solution of 1,2-diazetidine (1 
molar equiv.) in THF at -78 oC was added the solution of LiDBB until the dark 
green colour persisted for more than a minute. The reaction mixture was stirred 
for a further 30 minutes and then quenched by the addition of saturated aqueous 
NH4Cl (1 mL). After warming to room temperature, Et2O (2 mL) was added. 
The layers were separated and the aqueous layer extracted with Et2O (3 × 10 
mL). The combined organic layers were dried (MgSO4), filtered, and 
concentrated in vacuo. Purification on silica gel (ethyl acetate in hexane) 
afforded the desired product. 
 
(S)-Diethyl propane-1,2-diylbiscarbamate ((S)-290 
                                           
(S)-290 was synthesised according to General Procedure 5 with the following: 
(S)-280 (87 mg, 0.40 mmol), THF (2 mL) and stock LiDBB solution (2.7 mL, 
1.1 mmol approx.). Purification on silica gel (25% ethyl acetate in hexane) 
afforded (S)-290 (56 mg, 64%) as a white crystalline solid. [α]30D = -11.1 
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(EtOAc);  M.p 131.9-132.6 oC; IR (neat) 3308 (N-H), 2980 (CH3), 1681 (C=O) 
cm-1; 1H NMR (400 MHz, CDCl3), 5.28 (1H, br s, NH), 5.02-5.11 (1H, br m, 
NH), 4.02-4.10 (4H, m, CO2CH2CH3), 3.77 (1H, br m, H-2), 3.15-3.29 (2H, m, 
H-1), 1.19 (6H, t, J = 7.1 Hz, CO2CH2CH3), 1.12 (3H, d, J = 6.7 Hz, H-3); 13C 
NMR (100 MHz, CDCl3) 157.4 (1C, CO2CH2CH3), 156.6 (1C, CO2CH2CH3), 
60.9 (1C, CO2CH2CH3), 60.7 (1C, CO2CH2CH3), 47.6 (1C, C-2), 46.4 (1C, C-1), 
18.4 (1C, C-3), 14.6 (2C, CO2CH2CH3); MS (ES+) m/z = 241 [M+Na]+, HRMS 
(ES+) m/z calculated for C9H18N2O4Na [M+Na]+: 241.1159; found: 241.1157. 
   
Diethyl (3-phenylpropane-1,2-diyl)biscarbamate (291) 
                                            
291 was synthesised according to General Procedure 5 with the following: 282 
(64 mg, 0.21 mmol), THF (2 ml) and stock LiDBB solution (1.8 mL, 0.7 mmol 
approx.). Purification on silica gel (20% ethyl acetate in hexane) afforded 291 
(44 mg, 69%) as a white crystalline solid. [α]30D = +24.0 (EtOAc); M.p 87.1-
87.9 oC; IR (neat) 3322 (N-H), 2980 (CH3), 1684 (C=O), 1262 (C-O), 751 
(ArH) cm-1; 1H NMR (400 MHz, CDCl3) 7.18 (5H, m, ArH), 4.94 (2H, br s, 
NH), 4.05-4.13 (4H, m, CO2CH2CH3), 3.87-3.97 (1H, br m, H-2), 3.31 (1H, dt, 
J = 4.7, 14.0 Hz, H-1), 3.16-3.24 (1H, br m, H-1), 2.84-2.93 (1H, br m, H-3), 
2.76 (1H, dd, J = 7.2, 13.9 Hz, H-3), 1.23 (3H, t, J = 7.2 Hz, CO2CH2CH3), 1.21 
(3H, t, J = 7.2 Hz, CO2CH2CH3); 13C NMR (150 MHz, CDCl3) 157.4 (1C, 
CO2CH2CH3), 156.6 (1C, CO2CH2CH3), 137.3 (1C, ArC), 129.2 (2C, ArCH), 
128.7 (1C, ArCH), 126.7 (2C, ArCH), 61.1 (1C, CO2CH2CH3), 60.9 (1C, 
CO2CH2CH3), 53.1 (1C, C-2), 44.2 (1C, C-1), 38.9 (1C, C-3), 14.6 (2C, 
1
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CO2CH2CH3); MS (ES+) m/z = 295 [M+H]+, HRMS (ES+) m/z calculated for 
C15H23N2O4 [M+H]+: 295.1652; found: 295.1647. 
  
Diethyl 1[(3’-phenyl-1’,2’-oxazol-5’-yl)methyl]hydrazine-1,2-dicarboxylate 
(300) 
                                                
To a stirred solution of 251 (100 mg, 0.47 mmol), in CH2Cl2 (3 mL) was added 
phenyl hydroximoyl chloride (87 mg, 0.56 mmol) in CH2Cl2 (2 mL). The 
reaction was allowed to reach room temperature, stirred for 24 h then 
concentrated in vacuo. Purification on silica gel (20% ethyl acetate in hexane) 
afforded 300 (87 mg, 56%) as a white crystalline solid. M.p 57.1-58.1 oC; IR 
(neat) 3286 (N-H), 2978 (CH3), 1681 (C=O), 1208 (N-O), cm-1; 1H NMR (400 
MHz, CDCl3) 7.74-7.79 (2H, br m, ArH), 7.38-7.47 (3H, br m, ArH), 6.90-7.19 
(1H, br m, NH), 6.57 (br s, 1H, H-4’), 4.85 (2H, br s, NCH2Ar), 4.15-4.25 (4H, 
br m, CO2CH2CH3), 1.25 (6H, br m, CO2CH2CH3); 13C NMR (100 MHz, CDCl3) 
168.2 (1C, C-5’), 162.6 (2C, CO2CH2CH3), 155.8 (1C, C-3’), 130.1 (1C, ArCH) 
128.9 (2C, ArCH), 128.8 (1C, ArC), 126.8 (2C, ArCH), 101.5 (1C, C-4’), 63.2 
(1C, CO2CH2CH3), 62.3 (1C, CO2CH2CH3), 45.5 (1C, NCH2Ar), 14.4 (2C, 
CO2CH2CH3); MS (ES+) m/z = 356 [M+Na]+, HRMS (ES+) m/z calculated for 
C16H19N3O5Na [M+Na]+: 356.1217; found: 356.1221.     
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General Procedure 6 
                
To a solution of 3-methylene-1,2-diazetidine (1 molar equiv.) in CH2Cl2 at 0 oC 
was added tetracyanoethylene (1 molar equiv.). The solution was allowed to 
warm to room temperature and stirred for 16 h. The reaction mixture was 
concentrated in vacuo and the crude product was recrystallised from ethyl 
acetate. 
 
Diethyl 5,5,6,6-tetracyano-1,2-diazaspiro[3.3]heptane-1,2-dicarboxylate 
(303) 
                                                    
303 was synthesised according to General Procedure 6 with the following: 251 
(0.05 g, 0.23 mmol), tetracyanoethylene (0.03 g, 0.23 mmol) and CH2Cl2 (3 
mL). Recrystallisation from ethyl acetate afforded 303 (0.067 g, 98%) as a 
white crystalline solid. M.p. 184.3-185.1 oC; IR (neat) 2985 (CH3), 1718 (C=O), 
1269 (C-O) cm-1; 1H NMR (400 MHz, CD3CN), 4.57 (1H, d, J = 17.7 Hz, H-3), 
4.54 (1H, d, J = 17.8 Hz, H-3), 4.17-4.41 (5H, m, H-7, 2 x CO2CH2CH3), 3.71 
(1H, d, J = 15.9 Hz, H-7), 1.35 (3H, t, J = 7.1 Hz, CO2CH2CH3), 1.31 (3H, t, J = 
7.1 Hz, CO2CH2CH3); 13C NMRi (100 MHz, CD3CN) 159.1 (1C, CO2CH2CH3), 
155.2 (1C, CO2CH2CH3), 111.2 (1C, CN), 110.7 (1C, CN), 108.4 (1C, CN), 
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  Only	  one	  carbon	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  for	  C-­‐5/C-­‐6	  
N N
CO2R2R2O2C
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107.8 (1C, CN), 68.3 (1C, C-4), 63.3 (1C, CO2CH2CH3), 62.7 (1C, 
CO2CH2CH3), 57.7 (1C, C-3) 40.6 (1C, C-7), 31.4 (1C, C-5 or C-6), 13.3 (1C, 
CO2CH2CH3), 13.3 (1C, CO2CH2CH3); MS (ES+) m/z = 365 [M+Na]+, HRMS 
(ES+) m/z calculated for C15H14N6O4Na [M+Na]+: 365.0969; found: 365.0967.  
 
Di-iso-propyl 5,5,6,6-tetracyano-1,2-diazaspiro[3.3]heptane-1,2-
dicarboxylate (305) 
                                                          
305 was synthesised according to General Procedure 6 with the following: 273 
(0.05 g, 0.21 mmol), tetracyanoethylene (0.026 g, 0.21 mmol) and CH2Cl2 (3 
mL). Recrystallisation from ethyl acetate afforded 305 (59 mg, 80%) as a white 
crystalline solid. M.p. 172.1-172.9 oC; IR (neat) 2986 (CH3), 1704 (C=O), 2365 
(-CN) 1285 (C-O) cm-1; 1H NMR (400 MHz, CD3CN) 5.12 (1H, sept, J = 6.4 
Hz, CO2CH(CH3)2), 4.99 (1H, sept, J = 6.3 Hz, CO2CH(CH3)2), 4.56 (1H, d, J = 
15.3 Hz, H-3), 4.54 (1H, d, J = 15.3 Hz, H-3), 4.22 (1H, d, J = 15.8 Hz, H-7), 
3.69 (1H, d, J = 15.8 Hz, H-7), 1.36 (6H, t, J = 6.2 Hz, CO2CH(CH3)2), 1.31 
(6H, t, J = 6.3 Hz, CO2CH(CH3)2); 13C NMRi (400 MHz, CD3CN) 158.8 (1C, 
CO2CH(CH3)2), 154.4 (1C, CO2CH(CH3)2), 111.2 (1C, CN), 110.8 (1C, CN), 
108.5 (1C, CN), 107.3 (1C, CN), 72.1 (1C, CO2CH(CH3)2), 71.0 (1C, 
CO2CH(CH3)2), 68.4 (1C, C-4), 57.9 (1C, C-3), 40.6 (1C, C-7), 31.2 (1C, C-5 or 
C-6), 20.7 (2C, CO2CH(CH3)2), 20.6 (2C, CO2CH(CH3)2); MS (ES+) m/z = 393 
[M+Na]+, HRMS (ES+) m/z calculated for C17H18N6O4Na [M+Na]+: 393.1282; 
found: 393.1284.        
N N
CO2iPriPrO2C
CN
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Di-tert-butyl-5,5,6,6-tetracyano-1,2-diazaspiro[3.3]heptane-1,2-
dicarboxylate (304) 
                                              
304 was synthesised according to General Procedure 6 with the following: 252 
(50 mg, 0.19 mmol), tetracyanoethylene (24 mg, 0.19 mmol) and CH2Cl2 (3 
mL). Recrystallisation from ethyl acetate afforded 304 (52 mg, 71%) as a white 
crystalline solid. M.p.  145.8-146.4 oC; IR (neat) 2981 (CH3), 1705 (C=O), 1367 
(C-O) cm-1; 1H NMR (400 MHz, CO(CD3)2) 4.91 (1H, d, J = 10.4 Hz, H-3), 
4.65 (1H, d, J = 10.4 Hz, H-3), 4.35 (1H, d, J = 15.1 Hz, H-7), 4.02 (1H, d, J = 
15.2 Hz, H-7), 1.58 (9H, s, C(CH3)3), 1.53 (9H, s, C(CH3)3); 13C NMRi (100 
MHz, CO(CD3)2) 159.9 (1C, CO2C(CH3)3), 154.7 (1C, CO2C(CH3)3), 112.6 (1C, 
CN), 112.1 (1C, CN), 110.3 (1C, CN), 109.3 (1C, CN), 84.9 (1C, CO2C(CH3)3), 
83.5 (1C, CO2C(CH3)3), 70.1 (1C, C-4), 59.6 (1C, C-3), 42.2 (1C, C-7), 32.2 
(1C, C-5 or C-6), 28.2 (3C, CO2C(CH3)3), 28.1 (3C, CO2C(CH3)3); MS (ES+) 
m/z = 421 [M+Na]+, HRMS (ES+) m/z calculated for C19H22N6O4Na [M+Na]+: 
421.1595; found: 421.1593. 
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Diethyl 5,5,6,6-tetracyano-7,7-dimethyl-1,2-diazaspiro[3.3]heptane-1,2-
dicarboxylate (306) 
                                               
306 was synthesised according to General Procedure 6 with the following: 274 
(50 mg, 0.21 mmol), tetracyanoethylene (26 mg, 0.21 mmol) and CH2Cl2 (3 
mL). Recrystallisation from ethyl acetate afforded 306 (30 mg, 39%) as a white 
crystalline solid. M.p. 137.7-138 oC; IR (neat) 2989 (CH3), 2333 (-CN), 1756 
(C=O), 1270 (C-O) cm-1; 1H NMR (400 MHz, CD3CN) 4.38-4.50 (3H, m, 
CO2CH2CH3, H-3), 4.22-4.31 (3H, m, CO2CH2CH3, H-3), 1.72 (3H, s, 
>C(CH3)2), 1.63 (3H, s, >C(CH3)2), 1.35 (3H, t, J = 7.1 Hz, CO2CH2CH3), 1.31 
(3H, t, J = 7.1 Hz, CO2CH2CH3); 13C NMR (100 MHz, CD3CN) 159.2 (1C, 
CO2CH2CH3), 153.8 (1C, CO2CH2CH3), 109.8 (1C, CN), 109.5 (1C, CN), 109.1 
(1C, CN), 107.3 (1C, CN), 76.3 (1C, C-4), 63.0 (1C, CO2CH2CH3), 62.9 (1C, 
CO2CH2CH3), 53.9 (1C, C-3), 53.1 (1C, C-7), 44.7 (1C, C-5 or C-6), 43.8 (1C, 
C-5 or C-6), 24.2 (1C, >C(CH3)2), 20.9 (1C, >C(CH3)2), 13.3 (1C, CO2CH2CH3), 
13.2 (1C, CO2CH2CH3); MS (ES+) m/z = 393 [M+Na]+, HRMS (ES+) m/z 
calculated for C17H19N6O4 [M+Na]+: 371.1462; found: 371.1465. 
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Diethyl 5-oxa-4,5-diazaspiro[2.3]-1,2-dicarboxylate (310) 
                                               
Firstly, a solution of DMDO in acetone was prepared as follows: a 250 mL 3-
necked round bottomed flask fitted with a condenser was connected to a 50 mL 
receiving flask cooled to -78 oC.  NaHCO3 (12 g, 143 mmol), acetone (13 ml, 
177 mmol) and water (20 ml, 1.11 mol) were added to the 3-necked flask and 
cooled to 0 oC. Oxone (25 g, 164 mmol) was added to the flask portion-wise 
with vigourous stirring. A sheet of aluminium foil containing dry ice was then 
wrapped around the condenser followed by the attachment of a water aspirator. 
The reaction was then stirred under these conditions for 1 h whereby several mL 
of solution had been collected within the 50 mL flask. The concentration of the 
solution was determined to be approximately 0.05 M using iodometric titration. 
The freshly prepared solution of DMDO (4 mL, 0.02 mmol approx.) was added 
to a stirred solution of 251 (24 mg, 0.11 mmol) in CH2Cl2 (1 mL) at 0 oC. The 
reaction mixture was allowed to warm to room temperature, stirred for 1 h and 
then concentrated in vacuo to afford 310 (25 mg, 96%) as a colourless oil. IR 
(neat) 2983 (CH3), 1698 (C=O), 1102 (C-O) cm-1; 1H NMR (400 MHz, CDCl3) 
4.58 (1H, d, J = 10.0 Hz, H-3), 4.44 (1H, d, J = 10.1 Hz, H-3), 4.15-4.32 (4H, 
m, CO2CH2CH3), 3.69 (1H, d, J = 4.0 Hz, H-6), 2.85 (1H, d, J = 3.9 Hz, H-6), 
1.30 (3H, t, J = 7.1 Hz, CO2CH2CH3), 1.29 (3H, t, J = 7.1 Hz, CO2CH2CH3); 13C 
NMR (100 MHz, CDCl3) 160.8 (1C, CO2CH2CH3), 156.8 (1C, CO2CH2CH3), 
71.2 (1C, C-4), 63.2 (1C, CO2CH2CH3), 62.9 (1C, CO2CH2CH3), 56.4 (1C, C-3), 
47.5 (1C, C-6), 14.3 (1C, CO2CH2CH3), 14.3 (1C, CO2CH2CH3); MS (ES+) m/z 
N N
O
CO2EtEtO2C 1
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= 253 [M+Na]+, HRMS (ES+) m/z calculated for C9H14N2O5Na [M+Na]+: 
253.0795; found: 253.0795. 
       
Ethyl ([{1-[(ethoxycarbonyl)amino]cyclopropyl}methyl)carbamate (312) 
                                           
To a stirred solution of 251 (150 mg, 0.70 mmol) in CH2Cl2 (4 mL), was added 
CH2CI2 (282 µL, 3.5 mmol) followed by ZnEt2 (3.5 mL, 3.5 mmol, 1M in 
hexanes) and the reaction was stirred at 25 oC for 24 h. The reaction was 
quenched with NH4Cl(aq) (2 mL) and extracted with CH2Cl2 (3 x 5 mL). The 
combined organic layers were dried over magnesium sulphate and concentrated 
in vacuo. The residue was taken up in THF (2 mL) and 1M HCl (3 mL) and 
stirred at 80 oC for 4 h. Upon cooling, the reaction mixture was extracted with 
diethyl ether (3 x 10 mL). The combined organic layers were dried over 
magnesium sulphate and concentrated in vacuo. Purification on silica gel (30% 
ethyl acetate in hexane) afforded 312 (34 mg, 21%) as a white solid.  1H NMR 
(400 MHz, CDCl3) 5.61 (1H, br s, NH), 5.10 (1H, br s, NH), 4.07-4.13 (4H, m, 
CO2CH2CH3), 3.28 (2H, br m, H-2), 1.24 (6H, t, J = 7.0 Hz, CO2CH2CH3), 0.83 
(4H, br s, 4H, CH2CH2); MS (ES+) m/z = 253 [M+Na]+, HRMS (ES+) m/z 
calculated for C10H19N2O4 [M+H]+: 231.1339; found: 231.1430. 
 
 
 
 
 
NHCO2EtEtO2CHN 1
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Appendix 1 
1H NMR spectra (400 MHz) of 235 
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Appendix 2 
1H NMR Spectra (400 MHz) of (±)-290 in the presence (S)-(+)-1-(9-Anthryl)-
2,2,2-trifluoroethanol (focused on methyl group splitting). 
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Appendix 2 
1H NMR Spectra (400 MHz) of (R)-290 in the presence (S)-(+)-1-(9-Anthryl)-
2,2,2-trifluoroethanol spiked with (±)-290 (focused on methyl group splitting). 
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Appendix 2 
1H NMR Spectra (400 MHz) of (S)-290 in the presence (S)-(+)-1-(9-Anthryl)-
2,2,2-trifluoroethanol (focused on methyl group splitting). 
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Appendix 3 
1H NMR (400 MHz) spectra of 300 
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Appendix	  4	  
	  
1H NMR Spectrum of 308 
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Appendix 5 
 
HPLC retention times using a solvent system of iPrOH in hexane on a Chiralcel 
AD column at 1.0 mL/min. UV absorbance was measured at 220 nm. 
 
 
 
 
substrate R1 R2 iPrOH (%) 1st  peak  
rt (min)  
2nd  peak  
rt (min) 
280 Et H 03 20.96 23.44 
284 tBu H 01 9.20 9.93 
282 Et Ph 05 17.83 20.74 
285 Et C6H4tBu 05 14.65 19.58 
286 Et Naphthyl 04 16.02 18.64 
287 Et C6H4OMe 02 30.22 32.67 
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